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(57) ABSTRACT 
The invention provides systems and methods for manipulat-
ing, e.g., optimizing and controlling, biological systems, e.g., 
for eliciting a more desired biological response of biological 
sample, such as a tissue, organ, and/or a cell. In one aspect, 
systems and methods of the invention operate by efficiently 
searching through a large parametric space of stimuli and 
system parameters to manipulate, control, and optimize the 
response ofbiological samples sustained in the system, e.g., a 
bioreactor. In alternative aspects, systems include a device for 
sustaining cells or tissue samples, one or more actuators for 
stimulating the samples via biochemical, electromagnetic, 
thermal, mechanical, and/or optical stimulation, one or more 
sensors for measuring a biological response signal of the 
samples resulting from the stimulation of the sample. In one 
aspect, the systems and methods of the invention use at least 
one optimization algorithm to modify the actuator's control 
inputs for stimulation, responsive to the sensor's output of 
response signals. The compositions and methods of the inven-
tion can be used, e.g., to for systems optimization of any 
biological manufacturing or experimental system, e.g., biore-
actors for proteins, e.g., therapeutic proteins, polypeptides or 
peptides for vaccines, and the like, small molecules (e.g., 
antibiotics), polysaccharides, lipids, and the like. Another use 
of the apparatus and methods includes combination drug 
therapy, e.g. optimal drug cocktail, directed cell prolifera-
tions and differentiations, e.g. in tissue engineering, e.g. neu-
ral progenitor cells differentiation, and discovery of key 
parameters in complex biological systems. 
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APPARATUS AND METHODS FOR 
MANIPULATION AND OPTIMIZATION OF 
BIOLOGICAL SYSTEMS 
RELATED APPLICATIONS 
This application claims priority from U.S. provisional 
application Ser. No. 60/629,500 filed Nov. 18, 2004, which is 
expressly incorporated herein by reference in its entirety and 
for all purposes. 
STATEMENT OF RIGHTS TO INVENTIONS 
MADE UNDER FEDERALLY SPONSORED 
RESEARCH 
This invention was made withU.S. Government support of 
Grant No. NCC2-1364, awardedby NASA. The U.S. govern-
ment has certain rights to this invention. 
TECHNICAL FIELD 
The invention provides apparatus and methods for con-
ducting automatic analysis and manipulation, e.g., experi-
ments and systems optimization, on biological samples, e.g., 
viable biological samples, including, but not limited to cells, 
tissues, organs cultures and the like, e.g., plant and mamma-
lian cells, a cell culture, cell fragments and/or cell organelles, 
a tissue, an isolated organ, a microorganism, e.g., bacteria, 
protozoa, yeast and viruses. 
In alternative aspects, systems include a device for sustain-
ing cells or tissue samples, one or more actuators for stimu-
lating the samples via biochemical, electromagnetic, thermal, 
mechanical, and/or optical stimulation, one or more sensors 
for measuring a biological response signal of the samples 
resulting from the stimulation of the sample. In one aspect, 
the systems and methods of the invention use at least one 
optimization algorithm to modify the actuator's control 
inputs for stimulation, responsive to the sensor's output of 
response signals. The compositions and methods of the inven-
tion can be used, e.g., for, but not limited to, the following 
applications: systems optimization of any biological manu-
facturing or experimental system, e.g., bioreactors for pro-
teins, polypeptides or peptides for vaccines, and the like, 
directing differentiation of cells to a specific property, e.g., 
therapeutic proteins, polypeptides or peptides for vaccines, 
and the like, and determining specific combination of ligands 
and their corresponding concentrations in drug screening sys-
tems, small molecules (e.g., antibiotics), polysaccharides, 
lipids, and the like. 
BACKGROUND 
Sophisticated biological systems, as often occur in nature, 
such as cells, tissues, and organs in the human body for 
example, are capable of responding to external chemical and/ 
or physical stimuli ("input variables" in some systems par-
lance). Such stimuli can additionally be applied as spatial or 
temporal gradients. The responses of biological systems can 
nonlinearly depend on the stimuli in a complex interplay of 
multiple variables comprising external stimuli from the envi-
ronment and internal factors within the biological system. 
This interplay can involve synergistic and antagonistic rela-
tionship among the multiple input variables. 
As a result of such complexity, It canbe difficult to manipu-
late a biological system, such as a cell, a group of cells, and 
organ or tissue, to behave in a desirable or nearly optimal way 
without understanding the following: (i) the effects that each 
2 
input variable (e.g., type of control input) has on a system, (ii) 
the different possible states of each variable (specific param-
eter of the control input), (iii) how those states affect the 
overall system, and (iv) the effects of interactions among the 
5 variables. The inability to manipulate a complex biological 
system posts challenges to elucidating mechanisms of cellu-
lar processes although such information can contribute sig-
nificantly to the advancement of basic research and medical 
applications. Further, cellular processes can be dynamic, sto-
chastic, nonlinear, multi-parametric, and/or possess memory 
effects. An example is cells which regulate their activities by 
integrating multiple external stimuli using internal and exter-
nal cellular signal transduction networks. A signal transduc- 
15 tion network is a cascade of biochemical reactions in the cells 
that can modify the cellular activity, such as a transcription 
factor activity in response to the binding of an external stimu-
lus such as a ligand that binds to a corresponding receptor. 
In a biological experiment for understanding the above- 
20 described signal transduction pathway, each stimulus, for 
example a ligand such as a drug or a cytokine, or other 
changes in the physical or chemical environment, can be 
tested independently, via an independent variation approach. 
Elements in signal transduction pathways that responds to a 
25 stimulus can be identified in an effort to reconstruct the signal 
transduction pathway and associated biological responses 
from downstream cellular processes. Due to the complexity 
of biological systems, the transduction pathway identification 
and reconstruction process can be extremely time-consuming 
3o and typically provides only partial information on the path-
way. Furthermore, interactions between or among stimuli can 
be missed by such an independent variation approach. There-
fore, important information in the combinatorial control, 
which can occur naturally in biological systems, is unavail- 
35 able. 
In combinatorial control, the combinations of the inputs 
can interact nonlinearly, in an antagonistic and/or a synergis-
tic fashion. Instead of one to one correspondence of the input 
and output relationships, specific combinations can result in 
4o different responses. For example, it is estimated that only 
about 160 transcription factors exist in the yeast genome, but 
yeast cells contain thousands of co-regulated sets of genes. 
Further, it is difficult to determine combinations of control 
inputs, such as a specific ligands and specific concentrations 
45 of the ligands, for eliciting a desired response from a biologi-
cal sample representing a biological system. Examples of 
other biological experiments that illustrate problems associ-
ated with the determination of combinatorial control include 
specific combinations of drugs and their corresponding con- 
50 centrations in combination drug treatment, or in identifying 
the proper combination of environment cues in nature for a 
specific biological response. 
One approach is to test all the combinations of the different 
stimuli (e.g., different ligands, or chemical or physical con- 
55 ditions) and the different states of each stimulus (e.g., differ- 
ent concentrations of a specific ligand, or different values of 
pH, temperature, shear stress, electrical field, magnetic field, 
etc.). However, the number of tests (experiments) required 
increases exponentially with the number of different stimuli 
60 (or "input variables" or "control inputs" in some systems 
terminology). The number of tests can become impracticably 
large in terms of cost and time for large numbers of input 
variables. For example, testing the effectiveness of a six-drug 
combination cocktail on a tissue or cell sample, assuming: 
65 only ten different concentrations per drug is used, requires 
106 or one million tests in order to identify a nearly optimal 
blend of concentrations. The identification of substantially 
US 8,232,095 B2 
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optimal stimulus conditions for a desired biological response 	 variables) for eliciting a desired biological system response, 
with a more limited number of tests is very desirable. 	 e.g., cell differentiation, drug cocktail, and determining spe- 
For decades, flu vaccines have been manufactured growing 	 cific combination of ligands and their corresponding concen- 
viruses in millions of live, fertilized eggs. The system works 	 trations in drug screening system. These embodiments can 
well, but it is time consuming and hard to ramp up quickly in 5 provide a way to determine the variables, the (e.g., types of 
a public health emergency. The threat of a flu pandemic 	 control input) that are important for a desired system 
demands new methods for developing newer, faster produc- 	 response, and states of each important variable (specific 
tion systems for vaccines, including vaccines for flu, SARS 	 parameter of the control input) that elicit a substantially opti- 
and the like. Cell-based production methods grow the flu 	 mal biological system response. These embodiments can 
virus in steel vats filled with living cells derived from mon-  io obviate the need to run a large number of tests, thereby dra- 
keys, dogs, humans or even insects. Some vaccines produced 	 matically reducing the time and resources required to identify 
this way have won limited approval in Europe, but none has 	 input variables and corresponding values to elicit an opti- 
been cleared for use in the United States. 	 mized, e.g., a substantially optimum (or nearly optimized 
i.e., minimal optimization is sufficient) biological system 
SUMMARY 	 15 response. 
In one embodiment, a system of the invention comprises: 
The invention provides systems and methods manipulat- 	 (i) a cell, organ or tissue culture device, a bioreactor, an 
ing, controlling, optimizing biological systems, e.g., for elic- 	 artificial organ system, including similar devices or systems, 
iting a more desired biological response of biological sample, 	 for sustaining biological samples representative of (e.g., 
such as a tissue, organ, and/or a cell. In one aspect, systems 20 derived from) the biological system to be studied or manipu- 
and methods of the invention operate by monitoring stimuli 
	
lated, as in a manufacturing biosystem; (ii) one or more 
and conditions in a biosystem, including parameters or rep- 	 actuators for stimulating the samples, e.g., via chemical, elec- 
resentative biological samples sustained in the system. In 	 tromagnetic, thermal, mechanical, optical, and/or other envi- 
alternative aspects, systems of the invention include a device 	 ronmental stimulation; (iii) one or more sensors for measur- 
for sustaining cells or tissue samples, one or more actuators 25 ing the response signal of the samples resulting from the 
for stimulating the samples via biochemical, electromagnetic, 	 stimulation; and (iv) a controller executing a smart search 
thermal, mechanical, and/or optical stimulation, one or more 	 algorithm to modify the actuator's control inputs for subse- 
sensors for measuring a biological response signal from or 	 quent biological sample manipulation and/or stimulation 
condition in a sample resulting from the growth and/or stimu- 	 responsive to the sensors' outputs responsive to biological 
lation of the sample. In one aspect, the systems and methods 30 sample responses. 
of the invention comprise at least one algorithm, e.g., an 	 Embodiments can also comprise appropriate software and 
optimization algorithm such as a smart non-linear optimiza- 	 hardware components to provide user-interface and data 
tion search algorithm, e.g., in the context of an interactive 	 analysis capabilities to enable user monitor and control of the 
software and hardware system, e.g., as a computer imple- 	 automatic optimization process. Thus, the invention com- 
mented method. 	 35 prises computer program products for implementing system 
The algorithm, e.g., optimization algorithm, can be used to 	 optimization comprising smart non-linear optimization 
monitor and/or control any or all aspects of a system, e.g., a 	 search algorithms, e.g., a simulated annealing algorithm, a 
biosystem, including environmental parameters, system 	 stochastic local search algorithm, a stochastic hill-climbing 
inputs and system outputs. In one aspect, a smart non-linear 	 algorithm, a Metropolis-Hastings sampler algorithm, a 
optimization search algorithm is used to monitor stimuli and 40 greedy randomized adaptive search algorithm, an evolution- 
conditions in a biosystem, e.g., to modify the actuator's con- 	 ary algorithm, a genetic algorithm, a taboo search algorithm, 
trol inputs for stimulation responsive to a sensor's output of 	 and/or a Gur Game algorithm, or any combination thereof. 
response signals. Smart non-linear optimization search algo- 	 The invention also provides computer implemented methods 
rithms used in the systems and methods of the invention can 	 comprising these algorithms for automatic optimization pro- 
comprise, e.g., a simulated annealing algorithm, a stochastic 45 cesses, including for the monitoring and/or control of experi-
local search algorithm, a stochastic hill-climbing algorithm, a 	 mental and manufacturing biosystems. 
Metropolis-Hastings sampler algorithm, a greedy random- 	 Embodiments can utilize biological system response infor- 
ized adaptive search algorithm, an evolutionary algorithm, a 	 mation obtained from the measurements by the sensors. 
genetic algorithm, a taboo search algorithm, and/or a Gur 	 Based partly on such information, in some embodiments a 
Game algorithm, or any combination thereof. 	 50 stochastic search algorithm (e.g., a smart non-linear optimi- 
The compositions and methods of the invention can be 	 zation search algorithm, such as a Gur Game search algo- 
used, e.g., for, but not limited to, the following applications: 	 rithm) can iteratively determine the input variables for 
systems manipulation and/or optimization of any biological 	 achieving a desired biological system response. Cells or tis- 
manufacturing or experimental system, e.g., bioreactors for 	 sue samples can be sustained in a device that can maintain 
proteins, polypeptides or peptides for vaccines, and the like, 55 desired physical and chemical states of the biological samples 
directing differentiation of cells to a specific property, and 
	
for a predetermined (e.g., extended) period of time. Actua- 
determining specific combination of ligands and their corre- 	 tors, including biochemical and physical, can be provided to 
sponding concentrations in drug screening systems. The com- 	 generate temporal and/or spatial stimulation. The states and 
positions and methods of the invention can be used, e.g., to for 	 responses of the samples can be monitored with instruments 
systems optimization of any biological manufacturing or 6o and/or sensors. In one aspect, a controller implementing an 
experimental system, e.g., bioreactors for proteins, e.g., 	 algorithm, e.g., an optimization algorithm such as a stochastic 
therapeutic proteins, polypeptides or peptides for vaccines, 	 search algorithm, is used to automatically and iteratively 
and the like, small molecules (e.g., antibiotics), polysaccha- 	 modify the initial inputs in search of a more nearly optimal 
rides, lipids, and the like. 	 biological system response, e.g., output from a bioreactor, 
Some embodiments of the current invention provide sys-  65 e.g., a microfluidic cell culture. 
tems and methods to automatically, interactively, and/or 	 Four exemplary applications of embodiments of this inven- 
experimentally determine optimal control inputs (values of 	 tion comprise compositions and methods for the analysis, 
US 8,232,095 B2 
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manipulation and/or optimization of: (i) systems for the 	 mechanical and/or optical stimulation. In one aspect, the 
manufacturing of polypeptides (e.g., antibodies or cytok- 	 stimulus applied in step (d) for altering the at least one param- 
ines), small proteins (e.g., antigens for vaccines), small mol- 	 eter measured in step (c), or at least one other parameter, or a 
ecules (e.g., antibiotics, co-factors or vitamins), lipids, 	 combination thereof, within the product of manufacture com- 
nucleic acids, sugars and polysaccharides, and other mol-  5 prises a change in temperature, pH, oxygen or carbon dioxide 
ecules; (ii) systems for directed cell differentiation and/or 	 concentration, rate of exchange of cell or tissue culture nutri- 
proliferation, such as in tissue engineering; (iii) systems for 	 ents, rate of harvesting or removal of a cell or tissue culture 
combination drug discovery or drug validation, e.g., using 	 secreted product, or a combination thereof. 
cocktails of candidate drugs; and (iv) systems for discovery in 	 In one aspect, the algorithm is operably linked to the con- 
cell biology. 	 io troller, the sensor and/or the stimulator, or any other apparatus 
The invention provides systems for automatic manipula- 	 or system to which the system of the invention is also linked 
tion of a biological sample (any biological material, such as a 	 with or communicating with. In one aspect, more than one 
tissue, a cell, a virus, a plasmid and the like), comprising: (a) 	 algorithm is used, e.g., in parallel or multiplex linked sys- 
a product of manufacture operable to sustain a biological 	 tems, e.g., for communicating with another apparatus or sys- 
sample positioned therein; (b) at least one stimulator operable 15 tem to which the system of the invention is also linked with or 
to alter at least one parameter to which the biological sample 	 communicating with. 
is exposed; (c) at least one sensor operable to measure the at 	 In one aspect, the algorithm manipulates one or more 
least one parameter; and (d) a controller operably connected 	 parameters in the system to achieve a desired result from the 
to receive a signal from the at least one sensor such that the 	 biological sample or the system. The algorithm can comprise 
controller is responsive to the signal received from the sensor 20 an optimization algorithm to manipulate one or more param- 
to actuate the at least one stimulator to which it is operably 	 eters in the system to achieve an optimized desired result from 
connected, and the stimulator upon actuation provides a 	 the biological sample or the system. In alternative aspects, the 
stimulus to alter the at least one parameter measured in step 	 term "optimized" includes "nearly optimized" i.e., only 
(c), or at least one other parameter, or a combination thereof, 	 minimal optimization. In other words, an optimization by a 
within or affecting the product of manufacture, thereby 25 system or method of the invention can include partial, or 
manipulating the biological sample, wherein the controller 	 minimal, optimization, in addition to being capable, in some 
comprises or is operably connected to an algorithm to auto- 	 aspects, complete optimization. 
matically determine the stimulus given to the biological 
	
In one aspect, the desired result comprises growing, sus- 
sample, and the determination is based at least in part on the 	 taining and/or differentiating the biological sample in the 
at least one parameter measured by the sensor in step (c). 	 so product of manufacture. The algorithm can manipulate or 
In one aspect, the algorithm is an optimization algorithm or 	 optimize a quantitative aspect (the amount of) and/or a quali- 
a manipulation algorithm. The controller can comprise or is 	 tative aspect (the nature of) of the stimulus used to modify the 
operably connected to a computer program product compris- 	 one or more parameters in the system to achieve the desired 
ing the algorithm to automatically determine the stimulus 	 result from the biological sample. In one aspect, the desired 
given to the biological sample. The computer program prod-  35 result from the biological sample generated by the algo- 
uct can be operably contained within (e.g., programmed into) 	 rithm's manipulation of the system comprises manipulation 
a microchip, a microprocessor, a computer or a combination 	 or optimization of: cell growth, cell differentiation, cell vital- 
thereof. In one aspect, the controller comprises or is operably 	 ity, synthesis or secretion of a naturally occurring or recom- 
connected to an analog neural network, a hot wire circuitry, a 	 binant protein, a small molecule, an antibiotic, a polysaccha- 
microprocessor, a computer or a combination thereof, com-  4o ride, a virus, a nucleic acid and/or a lipid. The naturally 
prising the algorithm to automatically determine the stimulus 	 occurring or recombinant protein whose synthesis or secre- 
given to the biological sample. In one aspect, the optimization 	 tion is manipulated or optimized can comprise a cytokine, an 
algorithm comprises computer program product as set forth 	 antibody, an antigen or a structural protein. 
in FIG. 6; or, the optimization algorithm has a logic flow as set 	 In one aspect, the algorithm is set to direct an iterative 
forth in FIG. 6. 	 45 repetition of measuring at least one parameter in the system, 
In one aspect, the biological sample comprises a cell, a cell 	 actuating at least one stimulator and measuring at least one 
culture, a tissue, an isolated organ or an organ system or a cell 	 parameter modified in response to the stimulation, thereby 
isolate. The cell can be a bacterial cell, a protozoan cell, an 	 manipulating and/or optimizing the biological system to 
insect cell, a yeast cell, a plant cell or a mammalian cell, 	 achieve the desired result. The algorithm can be set to direct 
wherein optionally the mammalian cell is a human cell. In one 5o a dynamic change in the time period of each iteration. In one 
aspect, the product of manufacture comprises a bioreactor, 	 aspect, the algorithm is set to self-organize and/or self-opti- 
e.g., a composition comprising a cell culture apparatus. 	 mize the automatic manipulation of the biological sample. 
In one aspect, at least one parameter altered by the at least 	 In one aspect, the algorithm comprises a smart non-linear 
one stimulator comprises an environmental condition in the 	 optimization search algorithm, such as a simulated annealing 
product of manufacture. The environmental condition can be 55 algorithm, a stochastic local search algorithm, a stochastic 
altered by the at least one stimulator in the product of manu- 	 hill-climbing algorithm, a Metropolis-Hastings sampler algo- 
facture comprises temperature, pH, oxygen or carbon dioxide 	 rithm, a greedy randomized adaptive search algorithm, an 
concentration, nutrient or waste concentration, rate of 	 evolutionary algorithm, a genetic algorithm, a taboo search 
exchange of cell or tissue culture nutrients, rate of harvesting 	 algorithm, and/or a Gur Game algorithm, or any combination 
or removal of a cell or tissue culture secreted product, cell 60 thereof, or variations thereof. The smart non-linear optimiza- 
growth or differentiation rate, cell concentration, or a combi- 	 tion search algorithm can be set as a biased random walk 
nation thereof. 	 toward the desired result, and the desired result is set as a 
In one aspect, the stimulus applied in step (d) for altering 	 global optimum of a plurality of parameters. The algorithm 
the at least one parameter measured in step (c), or at least one 	 can set a global figure of merit (a reward function) to measure 
other parameter, or a combination thereof, within the product 65 the performance of the system as a whole to reach the desired 
of manufacture, or affecting the product of manufacture, 	 result. In one aspect, the algorithm can assign each measured 
comprises a biochemical, electromagnetic, thermal, 	 parameter any one of a pre-defined set of discrete states (or an 
US 8,232,095 B2 
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automaton), and different inputs for each parameter, or dif- 	 sured, or at least one other parameter, or a combination 
ferent inputs for the same parameter over time, result in a 	 thereof, within the product of manufacture comprises a 
different number of states and state values being assigned to 	 change in temperature, pH, oxygen or carbon dioxide con- 
each parameter, and during manipulation or optimization or 	 centration, rate of exchange of cell or tissue culture nutrients, 
the biological system each automatonmoves from one stateto 5 rate of harvesting or removal of a cell or tissue culture 
another based on being rewarded for causing a desired 	 secreted product, or a combination thereof. 
response, and the reward probabilistically drives the system 	 In one aspect of any method of the invention, the algorithm 
to the desired result. 	 manipulates one or more parameters in the system to achieve 
The invention provides methods for automatic manipula- 	 a desired result from the biological sample. The desired result 
tion or optimization of a biological sample comprising (a) io can comprise growing, sustaining and/or differentiating the 
providing at least one system of the invention; (b) measuring 	 biological sample (e.g., cells, tissues) in the product of manu- 
at least one parameter in the biological sample, wherein the 	 facture (e.g., a bioreactor). 
controller receives a signal from the at least one sensor; and 
	
In one aspect, the algorithm manipulates or optimizes a 
(c) providing a stimulus to the biological sample to alter the at 	 quantitative aspect (the amount of) and/or a qualitative aspect 
least one parameter measured in step (b), or at least one other 15 (the nature of) of the stimulus used to modify the one or more 
parameter, or a combination thereof, within the product of 	 parameters in the system to achieve the desired result from the 
manufacture by running the algorithm, wherein the algorithm 	 biological sample. The desired result from the biological 
determines the stimulus given to the biological sample, and 	 sample generated by the algorithm's manipulation or optimi- 
the determination is based at least in part on the at least one 	 zation of the system can comprise manipulation or optimiza- 
parameter measured by the sensor in step (b), thereby auto-  20 tion of: cell growth, cell differentiation, cell vitality, synthesis 
matically manipulating or optimizing the biological sample. 	 or secretion of a naturally occurring or recombinant protein, 
The invention also provides methods for automatic manipu- 	 a small molecule, an antibiotic, a polysaccharide, a virus, a 
lation or optimization of a biological sample to achieve a 	 nucleic acid and/or a lipid. In one aspect, the naturally occur- 
desired result comprising (a) providing at least one system of 	 ring or recombinant protein whose synthesis or secretion is 
the invention; (b) providing a first stimulus to the biological 25 manipulated or optimized comprises a cytokine, an antibody 
sample; (c) measuring at least one parameter in the biological 	 or a structural protein. 
sample in response to the first stimulus, wherein the param- 	 In one aspect, the algorithm is set to direct an iterative 
eter is measured by the controller receiving a signal from the 	 repetition of measuring at least one parameter in the system, 
at least one sensor; and (d) providing at least a second stimu- 	 actuating at least one stimulator and measuring at least one 
lus to the biological sample to alter the at least one parameter 30 parameter modified in response to the stimulation, thereby 
measured in step (b), or at least one other parameter, or a 	 manipulating and/or optimizing the biological system to 
combination thereof, to achieve a desired result, wherein the 	 achieve the desired result. The algorithm can be set to direct 
nature and amount of the at least second stimulus is deter- 	 a dynamic change in the time period of each iteration. In one 
mined and provided by running the algorithm, and the deter- 	 aspect, the algorithm is set to self-organize and self-optimize 
mination is based at least in part on the at least one parameter 35 the automatic manipulation of the biological sample. The 
measured by the sensor in step (c). In one aspect of any 	 algorithm can comprise a smart non-linear optimization 
method of the invention, the steps of the method can be 	 search algorithm, such as a simulated annealing algorithm, a 
iteratively repeated until a desired result is achieved. 	 stochastic local search algorithm, a stochastic hill-climbing 
In one aspect, the system used in any method of the inven- 	 algorithm, a Metropolis-Hastings sampler algorithm, a 
tion comprises sustaining or growing a biological sample 40 greedy randomized adaptive search algorithm, an evolution- 
within an apparatus for growing or sustaining or handling a 	 ary algorithm, a genetic algorithm, a taboo search algorithm, 
biological material, e.g., in an apparatus such as a bioreactor. 	 and/or a Gur Game algorithm, or any combination thereof. 
In one aspect, the biological sample comprises a cell, a cell 
	
In one aspect, the smart non-linear optimization search 
culture, a tissue, an isolated organ or an organ system or a cell 	 algorithm is set as a biased random walk toward the desired 
isolate. 	 45 result, and the desired result is set as a global optimum of a 
In one aspect of any method of the invention, the cell is a 	 plurality of parameters. In one aspect, the algorithm sets a 
bacterial cell, a protozoan cell, an insect cell, a yeast cell, a 	 global figure of merit (a reward function) to measures the 
plant cell or a mammalian cell, wherein optionally the mam- 	 performance of the system as a whole to reach the desired 
malian cell is a human cell. In one aspect of any method of the 	 result. The algorithm can assign each measured parameter 
invention, the product of manufacture comprises a bioreactor. 5o any one of a pre-defined set of discrete states (or an automa- 
The at least one parameter can be altered by the at least one 	 ton), and different inputs for each parameter, or different 
stimulator, and the parameter can comprise an environmental 
	
inputs for the same parameter over time, result in a different 
condition in the product of manufacture or affecting the prod- 	 number of states and state values being assigned to each 
uct of manufacture. In one aspect, the environmental condi- 	 parameter, and during manipulation and/or optimization of 
tion altered by the at least one stimulator in the product of 55 thebiological systemeach automatonmoves from one stateto 
manufacture comprises temperature, pH, oxygen or carbon 	 another based on being rewarded for causing a desired 
dioxide concentration, nutrient or waste concentration, rate of 	 response, and the reward probabilistically drives the system 
exchange of cell or tissue culture nutrients, rate of harvesting 	 to the desired result. 
or removal of a cell or tissue culture secreted product, cell 
	
The invention provides Systems for automatically manipu- 
growth or differentiation rate, cell concentration, or a combi-  60 lating or optimizing production of a product by a biological 
nation thereof. The stimulus applied in a step for altering the 	 system, comprising: (a) a bioreactor and a biological sample 
at least one parameter measured, or at least one other param- 	 positioned therein; (b) at least one stimulator operable to alter 
eter, or a combination thereof, within the product of manu- 	 at least one parameter to which the biological sample is 
facture can comprise a biochemical, electromagnetic, ther- 	 exposed; (c) at least one sensor operable to measure the at 
mal, mechanical and/or optical stimulation. 	 65 least one parameter; and (d) a controller operably connected 
In one aspect of any method of the invention, the stimulus 	 to receive a signal from the at least one sensor such that the 
applied a step for altering the at least one parameter mea- 	 controller is responsive to the signal received from the sensor 
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to actuate the at least one stimulator, and the stimulator upon 
actuation provides a stimulus to alter the at least one param-
eter measured in step (c), or at least one other parameter, or a 
combination thereof, within the bioreactor, thereby manipu-
lating the biological sample, wherein the controller com-
prises or is operably connected to a computer program prod-
uct comprising an algorithm operably linked to the stimulator 
to automatically determine the stimulus given to the biologi-
cal sample, and the determination is based at least in part on 
the at least one parameter measured by the sensor in step (c) 
and the rate or amount of product produced by a biological 
system, thereby automatically manipulating or optimizing 
production of the product by the biological system. 
The invention provides computer-implemented methods 
for automatically optimizing production of a product by a 
biological system comprising a method of the invention. The 
invention provides computer program products for automati-
cally optimizing production of a product by a biological sys-
tem, wherein the computer program product comprises a 
machine-readable medium including machine-executable 
instructions, the instructions being operative to cause a 
machine to run a computer-implemented method of the 
invention. The invention provides computer systems com-
prising a computer program product of the invention. 
Other features and aspects of the invention will become 
apparent from the following detailed description, taken in 
conjunction with the accompanying drawings, which illus-
trate, by way of example, the features in accordance with 
embodiments of the invention. The summary is not intended 
to limit the scope of the invention, which is defined solely by 
the claims attached hereto. The details of one or more 
embodiments of the invention are set forth in the accompa-
nying drawings and the description below. 
All publications, patents, patent applications, GenBank 
sequences and ATCC deposits, cited herein are hereby 
expressly incorporated by reference for all purposes. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a high level block diagram of an exemplary 
embodiment of the invention. 
FIG. 2 illustrates an exemplary microfluidic bioreactor 
according to an embodiment of the invention. 
FIG. 3 illustrates an exemplary embodiment of the inven-
tion at an intermediate level of detail. 
FIG. 4 illustrates another embodiment of the invention, 
showing fluorescent and phase contrast microscope sensors. 
FIG. 5 illustrates an environmental enclosure for some 
embodiments of the invention. 
FIG. 6 is a flow chart illustrating an exemplary Gur Game 
search algorithm, according to an embodiment of the inven-
tion. 
FIG. 7 shows a state diagram illustrating an exemplary Gur 
Game search algorithm that is used in an embodiment of the 
invention. 
FIG. 8 illustrates a substantially optimal biological system 
response as generated by an exemplary system of the inven-
tion. 
FIG. 9 illustrates a sensitivity analysis of individual cytok-
ines in combination, as determined by an embodiment of the 
invention. 
DETAILED DESCRIPTION 
The invention provides systems and methods for manipu-
lating, e.g., optimizing and controlling, biological systems by 
using an optimization algorithm set for the automatic 
manipulation of the biological sample to elicit a desired 
response from the biological sample. The systems and meth-
ods of the invention can be used to manipulate, control, or 
optimize any biological system, including but not limited to, 
5 the following applications: systems optimization of a biologi-
cal manufacturing or experimental system, e.g., bioreactors 
for proteins, polypeptides or peptides for vaccines, and the 
like, directing differentiation of cells to a specific property, 
and determining specific combination of ligands and their 
io corresponding concentrations in drug screening systems. The 
invention provides apparatus and methods for conducting 
automatic analysis and manipulation, e.g., experiments and 
systems optimization, on biological samples, e.g., viable bio-
logical samples, including, but not limited to cells, tissues, 
15 organs cultures and the like, e.g., plant and mammalian cells, 
a cell culture, cell fragments and/or cell organelles, a tissue, 
an isolated organ, a microorganism, e.g., bacteria, protozoa, 
yeast and viruses. The invention provides apparatus and 
methods for conducting automatic analysis and manipulation 
20 and/or systems optimization on manufacturing systems for 
biological products, such as proteins (e.g., cytokines, vac-
cines), small molecules (e.g., antibiotics), lipids, polysaccha-
rides, nucleic acids and the like. The invention provides appa-
ratus and methods for conducting automatic analysis and 
25 manipulation and/or systems optimization in tissue engineer-
ing systems, such as systems for directed cell proliferation or 
differentiation. The invention provides apparatus and meth-
ods for conducting automatic analysis and manipulation and/ 
or systems optimization in drug discovery systems, including 
so cell-based drug discovery or drug efficacy verification sys-
tems, particularly in combination drug discovery or efficacy 
validation, e.g., using cocktails of candidate drug com-
pounds. The invention provides apparatus and methods for 
conducting automatic analysis and manipulation and/or sys- 
35 tems optimization in cell biology systems, including experi-
mental systems, such as gene circuit, cell proliferation, pro-
grammed cell death (apoptosis) or signal transduction 
systems. 
In one aspect, the systems and methods of the invention are 
40 used to optimize the production of biological products, 
including polypeptide and peptides, e.g., antibodies, antigens 
or cytokines (including recombinant proteins), small mol-
ecules made by cell-based or in vitro biological systems, 
lipids, polysaccharides, nucleic acids, viruses, recombinant 
45 vectors and the like. Thus, in one aspect, the systems and 
methods of the invention are used to optimize the production 
of vaccines and medicines. In another aspect, the systems and 
methods of the invention are used to direct differentiation of 
cells into a group of cells with specific properties such as 
5o having a specific surface marker. In another aspect, the sys-
tems and methods of the invention are used to identify the 
specific combination of ligands and their corresponding con-
centrations. 
In the following description, reference is made to the 
55 accompanying drawings, which illustrate several embodi-
ments of the present invention. It is understood that other 
embodiments may be utilized and mechanical, composi-
tional, structural, electrical, and operational changes may be 
made without departing from the spirit and scope of the 
60 present disclosure. The following detailed description is not 
to be taken in a limiting sense, and the scope of the embodi-
ments of the present invention is defined only by the claims of 
the issued patent. 
Some portions of the detailed description which follows 
65 are presented in terms of procedures, steps, logic blocks, 
processing, and other symbolic representations of operations 
on data bits that can be performed on computer memory. In 
US 8,232,095 B2 
11 
	
12 
alternative aspects, the systems of the invention comprise a 
computer implemented method, a procedure, a computer 
executed step, a logic block, a process, etc., to be a self-
consistent sequence of steps or instructions leading to a 
desired result, as described herein. In one aspect, the steps are 
those utilizing physical manipulations of physical quantities, 
e.g., parameters in a biological system. These quantities can 
take the form of electrical, magnetic, or radio signals capable 
of being stored, transferred, combined, compared, and other-
wise manipulated by a computer system. In various aspects, 
these signals are referred to at times as bits, values, elements, 
symbols, characters, terms, numbers, or the like. Each step 
may be performed by hardware, software, firmware, human 
(operator) manipulation or any combinations thereof. 
Embodiments of the present invention provide apparatus 
and methods to determine the variables or parameters (the 
different types of control inputs or stimuli) and the specific 
value of each of the variables or parameters (e.g., a specific 
metric of each input or stimulus) that singly or in combination 
can elicit a desirable and/or substantially optimal response 
from a biological system, such as a biological sample. In 
alternative aspects, the biological sample comprises a single 
cell, a cell or tissue culture, or a tissue sample, or an isolated 
organ, without requiring knowledge of the internal mecha-
nisms of the biological system. 
The systems and methods of the invention can obviate or 
reduce the need to run a large, e.g., an impracticably large, 
number of tests. Embodiments can comprise: (i) a device for 
sustaining cells, cell or tissue cultures, or tissue samples, or 
organs; (ii) one or more actuators for stimulating a biological 
sample, e.g., via chemical, electromagnetic, thermal, 
mechanical, optical, and/or other environmental stimulation, 
according to a selected criterion; (iii) one or more sensors for 
measuring the corresponding responses of the samples result-
ing from the stimulation; and (iv) a controller executing an 
optimization algorithm to modify the actuator's control 
inputs for subsequent stimulation responsive to the sensors' 
outputs responsive to biological sample responses. Embodi-
ments can also include appropriate software and hardware 
components to provide user-interface and data analysis capa-
bilities to a enable user to monitor and control the automatic 
experimentation process. 
FIG. 1 illustrates a high level functional block diagram of 
an embodiment of the invention. In this embodiment, the 
exemplary device for sustaining cells, cell cultures, and tissue 
samples is a microfluidic cell culture device (a type of biore-
actor) 11. This exemplary device can sustain the cells and 
tissue samples for extended periods of time. The length of 
time required depends on the biological process and trans-
duction network under investigation, which can be up to 
months or even longer. The exemplary device can provide the 
basic elements for sustaining biological samples, such as 
growth factor, cytokine(s), extra-cellular matrix, tempera-
ture, pH, gases, and ions that are required for normal cell 
survival and processes. Some embodiments require ongoing 
monitoring and stimulation of biological samples under test. 
Embodiments of the sample-sustaining devices can allow 
integration of corresponding sensors and actuators. 
Referring again to FIG. 1, block 12 represents stimuli 
actuation to stimulate a biological sample within the exem-
plary microfluidic cell culture (bioreactor) 11 under control 
of controller 14. Some stimuli actuators may be integrated 
with microfluidic cell culture 11: for example, electrodes, 
temperature actuators, and mechanical actuators (or, in alter-
native aspects, stimuli actuators may be integrated in any 
form of bioreactor). Other stimuli actuator can be separate 
from microfluidic cell culture 11: for example various media 
and reagent pumps or valves under control of controller 14. 
Block 13 represents sensing responses of the biological 
sample. In this exemplary embodiment or in any other aspect 
of the invention, response sensing can include, without limi- 
5 tation: sensing chemicals in cell culture media, sensing intra-
cellular chemicals; sensing electrical fields and membrane 
potentials, and imaging of the biological sample using bright 
field, phase contrast, fluorescence, and/or atomic force 
microscopy. Block 14 represents the controlling function, 
io which in some embodiments can be implemented using a 
personal computer executing software. 
In this exemplary embodiment or in any other aspect of the 
invention, a device (e.g., a microfluidic cell culture device) 
can be fabricated, for example, by micromolding. In one 
15 aspect, the molding is polydimethylsiloxane (PDMS) (Syl-
gard 184) on a photoresist master mold to form fluid channels 
and/or other structures therein. Master molds for micromold-
ing can be fabricated by photolithography of positive photo-
resist SJR 5740 (MicroChem, 41001). Three layers of photo- 
2o resist can be spun on a glass substrate to achieve a final 
thickness of 60 µm. After curing, a PDMS replica can be 
carefully peeled off a master mold. The channels and/or other 
structures can then be sealed with cover glasses of about 0.17 
mm thick. A PDMS replica and a glass piece can each be 
25 oxidized for about 1 min in a plasma cleaner (for example, 
Harrick, PDC-001) prior to being immediately brought into 
contact with one another to achieve sealing of the channels in 
the PDMS replica to the glass piece. In this exemplary 
embodiment or in any other aspect of the invention, a device, 
30 e.g., a microfluidic channel, can be fabricated with glass, 
silicon, or polymeric materials using methods like dry etch-
ing, wet etching, laser processes, rapid prototyping, and tra-
ditional machining, using methods that are well known to one 
of ordinary skill in the art. In one aspect of a system of the 
35 invention comprising a microfluidic device, least one fluidic 
chamber or channel is required. Multiple chamber or channel 
arrays can also be provided for multiple simultaneous experi-
ments. 
FIG. 2 illustrates a top view of a microfluidic cell culture 
4o device 11 according to one embodiment of the invention. The 
cell culture is maintained in channel portion 24 for purposes 
of some examinations and sensings. Meandering channel sec-
tion 23 is provided to mix inputs 21 and 22. Input 22, for 
example, can be used to introduce growth medium, without 
45 any experimental factors, and input 21, for example, can be 
used to introduce growth medium with a known concentra-
tion of an experimental factor. The flow rates of media into 
inputs 21 and 22, as well as the design of meandering channel 
section 23 can be set to provide desired temporal or spatial 
50 gradients to channel portion 24. 
To sustain the cells and tissue samples for periods of time, 
a bioreactor, e.g., the exemplary microfluidic cell culture (bio 
reactor) device, can be loaded inside a closed chamber (e.g., 
Instec Inc, HCS60-STC20A) with temperature control, and 
55 adjusted to about 37° C. or some other selected temperature 
for the duration of the experiment (unless, of course tempera-
ture is an experimental variable, in which case the tempera-
ture could be varied in a controlled fashion over the course of 
the experiment). In one embodiment, the chamber can be 
60 filled with 5% of CO 2 mixed with air for maintaining the pH 
value of the medium. The diffusivities for 0 2 and CO2 in 
PDMS are about 4.1 X10-5  and 2.6x 10-5 cm2/sec respectively, 
so the ambient atmosphere can affect the solution within the 
microfluidic bioreactor. 
65 	 The embodiment illustrated in FIG. 3 shows microfluidic 
bioreactor 11 mounted within cavity 31 of closed chamber 
with temperature control 34. The temperature can be con- 
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trolled by controller 42 responsive to temperature sensor 41 	 metering media inflows. A pressure transducer (Honeywell, 
that is operable to measure a temperature of microfluidic 	 ACSX05DN for example), and a temperature probe can be 
bioreactor 11. A pressure sensor (not shown) can also be 	 operatively coupled to the bioreactor and monitored by a 
positioned to monitor pressure within the microfluidic biore- 	 controller (for example a personal computer with Labview 
actor. Gas supply 33 supplies gas to cavity 31 of closed 5 software from National Instruments). Fluidic connection(s) 
chamber with temperature control 34 via conduit 43. Mixing 	 of a bioreactor used to practice the systems or methods of the 
manifold 38 combines one or more incoming media solutions 	 invention can comprise providing for fresh medium, recircu- 
40a-40d (for an example of four) via valves or metering 	 lation of medium, removal processing and replacement 
pumps 39a-39d (again for an example of four) in a measured 	 of medium (e.g., to harvest a product, such as a recombinant 
way. 	 io protein, or a small molecule), removal of old medium or 
In alternative aspects, the systems of the invention can 	 detoxifying medium, biochemical stimulation (e.g., with 
comprise use of various media solutions and devices for con- 	 drugs, cytokines, hormones, etc), or mechanical (shear stress, 
trolling input and output of solutions; for example, different 	 pressure etc) control. 
incoming media solutions can contain different chemicals 	 Embodiments can be operated within a vertical clean 
and concentrations for either experimental or manufacturing 15 bench such as shown in FIG. 5 to minimize contamination 
purposes. The valves or metering pumps 39a-39b can be 	 from the external environment. In the embodiment of FIG. 5 
under the control of controller 42, which can thereby adjust 	 (shown in side cross-section), the requisite apparatus can sit 
the composition of the media being supplied to bioreactor 11. 	 on platform 61 within cavity 68 that is partially formed by 
Although mixing manifold 38 has been pictured as separate 	 platform 61, back wall 62, partial top wall 65, HEPA filter 66, 
from microfluidic bioreactor 11 in the embodiment as illus-  20 partial front wall 63, and first and second side walls that are 
trated, mixing manifold 38 can be integrated with microflu- 	 not shown. A blower 67 can be operably connected above 
idic bioreactor 11, for example as discussed above in relation 	 HEPA filter 66 to direct a filtered flow of air downward toward 
to FIG. 2. Such embodiments can provide an advantage in that 	 platform 61 and outward through front aperture 64 in a sub- 
the mixed media can be substantially pre-equalized in tem- 	 stantially laminar flow. Because positive pressure is main- 
perature with the temperature of the bioreactor. In the 25 tained within cavity 68, contamination by unfiltered outside 
embodiment of FIG. 3, the media effluent from bioreactor 11 	 air can be minimized even though front aperture 64 remains 
can pass through sensor block 35, that can comprise sensors 	 open for access. Such a system can allow long term cultiva- 
formetabolites, pH, or other chemical compounds for sensing 	 tion of cells and tissue samples with low contamination by 
purposes, that report back to controller 42. For the embodi- 	 outside particulate matter and organisms. 
ment of FIG. 3, the media effluent is discarded after passing 30 	 Different embodiments can be used for sustaining and 
through sensor block 35. In other embodiments, the media 	 growing biological samples and providing stimuli. For 
effluent can be recirculated through the bioreactor. Although 	 example, in a perfusion or microfluidic cell culture embodi- 
media effluent sensor block 35 has been illustrated as separate 	 ment, as described above, fluids can be continuously flowed 
from microfluidic bioreactor 11, at least some the functions of 	 through the bioreactor to recirculate medium, provide fresh 
media effluent sensor block 35 can be implemented within 35 medium, and/or dispense chemical reagents responsive to the 
microfluidic bioreactor 11, for example using electrochemi- 	 controller. Alternatively, biological samples can be stimu- 
cal or spectrophotometric sensors. In the embodiment of FIG. 	 lated and monitored at discrete time points, responsive to the 
3, a camera 37 is optionally included and operably connected 	 controller. In such embodiments, biological samples can be 
with controller 42. Camera 37 can be positioned to provide 	 replaced in between iterations of the processes of the inven- 
images of a biological sample within bioreactor 11 through a 40 tion, and the medium can be maintained in a static condition 
window in closed chamber with temperature control 34. 	 in the between experiments. In such embodiments, other 
In some embodiments, a bioreactor (e.g., the exemplary 	 bioreactor devices, such as tissue culture dishes, Petri dishes, 
microfluidic bioreactor) can be mounted on a fluorescence 	 culture flasks, and multiwell plates, can also be used with the 
microscope, such as Nikon TE200 or TE2000, for real-time 	 invention; in one aspect, proper conditions, such as gas con- 
monitoring such as illustrated in FIG. 4. In this embodiment, 45 centrations, pH values, and temperatures, are provided and/or 
bioreactor 11 is positioned above window 47 in temperature 	 maintained. The cell culture conditions can be provided and/ 
control stage 34 of sealed chamber 45. Atmosphere within 	 or maintained by externally placed devices, such as with an 
sealed chamber 45 can be provided by gas source 33 via 	 incubator and/or other type of perfusion chamber. The con- 
conduit 43. For simplicity of illustration, media inflow 55a 	 ditions can also be generated and/or maintained internally 
and effluent 55b are shown as being recirculated through 50 with integrated devices within the bioreactor. Cells and tissue 
media reservoir 40. Drawing elements 48 through 53 illus- 	 samples can be attached on a surface of the bioreactor. Alter- 
trate a confocal fluorescent microscope of the type that is well 	 natively, suspension cells can also be circulating in the biore- 
known to one of ordinary skill in the art. Light source 53 	 actor. Aperistaltic pump, a syringe pump, or apressure source 
shines through excitation filter 51 to dichoric beamspliter 49, 	 can be used for driving the fluid motion, as are well known to 
that directs a portion of the light through object lens assembly 55 one of ordinary skill in the art. Alternatively, integrated micro 
48, that projects it on a biological sample in the bioreactor. 	 pumps such as chemical, mechanical, or electrokinetic pumps 
Fluorescent emissions from the sample return through objec- 	 such as widely reported in the open literature covering nano- 
tive lens assembly 48, through dichroic mirror 49, and 	 technology developments can be used for generating fluid 
through emission filter 52 to image capture device 54. Fluo- 	 motion. 
rescence images can be captured, for example, with a 1024x 60 Perfusion manufacturing or experiment embodiments 
1024 pixel, 16-bit cooled CCD camera (Photometric 	 allow for the dynamic application of stimuli, such as drugs, 
CH350L). Window and light source 46 schematically indi- 	 inside a device, e.g., a bioreactor, such as a microfluidic 
cate a provision for including bright field and phase contrast 	 bioreactor. However, such fluid flow can create shear stress on 
microscope optics in additional embodiments of the inven- 	 channel sidewalls of the device (e.g., a microfluidic bioreac- 
tion. 	 65 tor). Such shear stress can increase at the relatively small 
Referring again to FIG. 3, in some embodiments, mini 	 channel dimensions encountered in some microfluidic biore- 
peristaltic pumps (Instech Inc, P625-10638) can be used for 	 actors. Cells in such microfluidic bioreactors can experience 
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shear stress. This can be taken into consideration when 
designing manufacturing processes or experiments according 
to various embodiments of the invention. Various types of 
cells have been characterized for response to such shear 
stress. The cellular mechanisms for sensing the shear stress 5 
are generally unknown, but in designing systems of the inven-
tion it can be taken into consideration that most shear stresses 
that can induce biological response changes are of the same 
order of magnitude, about one to ten dynes/cm 2 . The mini-
mum shear stress for inducing a change in a cell can be io 
cell-type specific. Shear stresses that are one to two orders of 
magnitude smaller than shear stresses known to elicit physi-
ological response changes can be used as controls for differ-
ent in vitro experiments or manufacturing processes or other 
experiments (e.g., cell-based, ex vivo) according to various 15 
embodiments of the invention. 
Various embodiments of the invention provide different 
types of actuators to stimulate biological samples under test. 
Various embodiments of the invention provide stimulation in 
space and time. Various embodiments of the invention take 20 
into consideration fundamental cell processes such as cell 
motility, proliferation, and development, which are regulated 
by spatial and/or temporal stimulations, either biochemical or 
physical. For example, the upstroke rate of a pulsatile flow has 
been reported to affect the gene expression and remodeling of 25 
artery endothelial cells. In general, failure to regulate growth, 
to control differentiation, or to establish the proper morpho-
logical connections can cause many pathological conditions. 
However, traditional cell cultivation techniques have only 
limited capabilities to investigate such factors. 30 
The ability to produce and apply these diverse stimulation 
landscapes with long-term monitoring using systems and 
methods of the invention is advantageous to cell study. 
Embodiments of the present invention can determine the 
proper control input parameters to induce desired biological 35 
responses, emulating natural signals, and/or therapeutic regi-
mens that can regulate biological processes. Therefore 
embodiments of the invention provide actuators for generat-
ing such stimulations and/or environment signals. In some 
embodiments, actuators can generate stimulation with spatial 40 
and temporal resolution relevant to a biological process of 
interest, and can be automatically modified by the controller 
executing an optimization or search algorithm. For example, 
using microfluidic techniques as discussed above, transient 
stimulation can be generated with different cytokines. Con- 45 
centration or duration of cytokine stimulation can be 
adjusted. Implementation of a microfluidic channel for cel-
lular study can dynamically alter the cell culture medium, and 
temporal control of the chemical stimulants can be achieved. 
In various aspects of the invention, bioreactors, e.g., 50 
microfluidic bioreactor embodiments of the invention, 
chemical/environmental stimuli that are measured, con-
trolled-manipulated and/or induced include, without limita-
tion, drugs, cytokines, soluble factors, dissolved gases, extra-
cellular matrices, cell-cell interactions, neurotransmitters, 55 
and various ions in steady state, or in temporal and/or spa-
tial gradients. In some embodiments, a spatial chemical con-
centration gradient can be achieved by merging of two fluid 
streams, e.g., in a microchannel(s) of a device of the inven-
tion, so that molecular diffusion can occur between them. In 60 
some embodiments, a zigzag channel can extend the fluid 
path and hence the diffusion time for developing an approxi-
mately linear concentration gradient. A spatial chemical gra-
dient of such embodiments can be characterized by merging 
streams of a dye, such as fluorescein, and another fluid, such 65 
as DI water. The concentration gradient of dye intensity can 
be experimentally determined by measuring the intensity pro- 
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file downstream in the channel. A concentration gradient can 
also by estimated by finite element simulation considering the 
convective/diffusive transport of the molecules. 
In additionto various chemical stimuli, some embodiments 
of the invention can provide physical stimuli such as 
mechanical forces, nano- or micro-structure environments, 
physical confinement, light intensities and wavelengths, tem-
peratures, magnetic fields, and electric fields to study 
responses of a biological sample. For instance, a shear stress 
gradient can be generated at an interface of two microchannel 
cross-sectional areas and/or geometries. In a first embodi-
ment, sudden enlargement of a straight channel produces a 
shear stress gradient around the corner of the junction, 
whereas distal regions of the enlarged section experience 
lower shear stresses which may be optimal for the culture of 
particular cells that can be immobilized in such a distal 
region. A different velocity landscape can be produced in a 
second embodiment having a converging channel. With a 
constant volumetric flow rate, the narrowing of the channel 
increases fluid velocity in the direction of flow which effec-
tively decreases the shear stress field. 
When the ranges of stimuli or environmental parameters 
that a biological sample can tolerate, such the concentration 
of a generated recombinant polypeptide, such as an antibody 
or a cytokine, or small molecule, or the magnitude of a 
mechanical force, or the concentration of cells in a culture 
system, are not known in advance, excessive stimulation or 
exposure, such as overdose or toxicity, may induce harmful 
effects to the samples. Moreover, the history of stimulation 
can also play important role in subsequent responses of bio-
logical samples. In such cases, various embodiments of the 
invention can use different biological samples of the same 
type, such as different batches of cells from a common cul-
ture, at different iterations of a study or a manufacturing 
process. 
Some embodiments incorporate perfusion systems (e.g., 
microfluidic perfusion systems) in a bioreactor to practice the 
invention, e.g., for performing dynamic stimulation and real-
time monitoring of biological samples to optimize or manipu-
late a biological sample, e.g., production of a biological prod-
uct. Sensors can measure not only the magnitude of responses 
but also the dynamic nature of the responses. In some embodi-
ments, such sensors can have high resolutions; for example, 
down to the single cell or sub-cellular level. Such capability 
provides information in sub-cellular processes, intercellular 
variations, population distributions, and ensemble averages. 
In some embodiments, the bioreactor for sustaining and 
stimulating the biological samples is integrated with sensors 
to allow the measurement cellular behaviors such as cell 
cycle, morphology, size change, proliferation rate, apoptosis 
rate, fusion rate, intracellular process. Such embodiments can 
be very useful for the study of cell dynamics, or manufactur-
ing processes where cell dynamics is important for produc-
tivity, particularly where real-time monitoring is required. 
The dynamics of transcription factor activity, gene expres-
sion, cell proliferation rate, and apoptosis rate in biological 
samples also can be measured and/or manipulated when prac-
ticing the systems and methods of the invention. For example, 
in microfluidic bioreactors of the invention, manufacturing 
processes or experiments can be performed to investigate or 
manipulate the dynamics of transcription factor activity, gene 
expression, cell proliferation rate, and/or apoptosis rate in 
biological samples. 
In alternative aspects of the invention, cell induction pro-
cedures are performed through non-invasive monitoring tech-
niques, such as the use of reporter genes. For instance, the 
transcription activity of a cell can be monitored using green 
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fluorescence protein (GPF) reporter. In various embodiments, 	 Because the responses of a biological sample under stimu- 
sensors can measure the biological responses and the states of 
	
lation can occur after a time delay, the measurements in the 
the system continuously, or at discrete time points. 	 systems and methods of the invention can incorporate time 
In various embodiments, sensors used to practice the 	 delay(s). The systems and methods of the invention can take 
invention can include the following types, without limitation; 5 into consideration the fact that time delay(s) from stimulation 
fluorescent (e.g. ratiometric, intensity, fluorescent decay rate, 	 to response for any particular biological sample can be an 
photobleaching rate, photobleaching after fluorescence 	 intrinsic property of that sample, result from the type or 
recovery); optical (e.g. optical density, calorimetric), electri- 	 magnitude of stimulus, and/or depend on the history of the 
cal (e.g. impedance, current etc); pressure; temperature, and 	 biological sample. In the control and optimization systems of 
chemical or biochemical. In various embodiments, sensors io the invention, the delay in time response can be considered as 
used to practice the invention can measure cell response to 	 latency of a control problem. While characterization of a 
any internal or external stimuli by, e.g., regulating gene 	 biological system's response time itself can be useful infor- 
expression associated with various cellular processes such as 	 mation for inducing a desired response, such information can 
proliferation, differentiation and signaling. The systems and 
	
be difficult to determine. In such a scenario, the response time 
methods of the invention can incorporate biotechnologies, for 15 itself can be considered as system parameter in the optimiza-
real-time screening of gene expression in living cells with any 	 tion processes and systems of the invention. 
tools, such as a reporter gene (GFP). The systems and meth- 	 Systems and methods of the invention can use optimization 
ods of the invention can incorporate micro/nano fabrication 	 or a smart search algorithm. These algorithms can be used to 
technology to optimize microenvironments for manufactur- 	 process information from biological sample sensor(s) to 
ing processes, or for experiments, e.g., for single cell studies. 20 adjust stimulators. The algorithms can adjust information for 
For example, in one aspect, the gene expression dynamics 	 combinations of stimuli to manipulate a response from a 
of transcription factor NF-KB and the house keeping gene 	 biological sample, or, to determine, measure or produce a 
beta-actin in HEK 293T cells can be screened at the transla- 	 more optimal response from a biological sample; this pro- 
tional and transcriptional level, respectively. To monitor NF- 	 cessing canbe in a closed-loop fashion. Systems and methods 
KB dynamics, the destabilized green fluorescence protein 25 of the invention can use information technologies, such as 
(d2EGFP, BD Biosciences, Rockville, Md.) can be utilized as 	 smart search algorithms, to organize and manipulate data 
a reporter gene. 	 resulting from measurements of responses in complex bio- 
The systems and methods of the invention can also incor- 	 logical networks, or generating stimuli to complex biological 
porate use of oligonucleotide probes, e.g., molecular bea- 	 networks (which include most bioreactor systems). Systems 
cons, which are oligonucleotide probes that have stem-and-  3o and methods of the invention can use focus on identifying 
loop structures and will undergo a spontaneous fluorogenic 	 individual components in biochemical and molecular bio- 
conformational change upon hybridization to a complemen- 	 logical systems and their interactions through signal trans- 
tary nucleic acid target. For example, an oligonucleotide 	 duction pathways. Systems and methods of the invention can 
probes, e.g., a molecular beacon, can be used to monitor 	 use knowledge about complex biological systems to design 
message RNA dynamics, e.g., the beta-actin mRNA dynam-  35 and apply optimization strategies, e.g., from the field of engi- 
ics measured in this example. Such a molecular beacon can be 	 neering. Systems and methods of the invention can consider 
extremely specific and sensitive. A molecular beacon specific 	 combinations of stimuli and their interactions in a desired 
to any mRNA, e.g., the beta-actin mRNA, can be designed 
	
biological system response. In this aspect, the technology is 
with the help of tools available in the public domain such as 	 fundamentally different from the traditional approaches of 
Basic Local Alignment Search Tool (BLAST) by National 40 conducting biological research in which each the effect of 
Center for Biotechnology Information (NCBI), mfold and 	 stimulus tends to be studied independently. 
RNAstructure programs. The characterization of the 	 Embodiments of the present invention take a systematic 
designed molecular beacon can be conducted with the ICY- 	 approach to the regulation of complex biological systems, 
CLERTM: (iCycler iQTM) real-time PCR detection system. 	 based on responses of a biological sample to different com- 
In some embodiments, the sensor measurements are used 45 binations of stimuli. In some aspect, rather than conducting 
that are non-invasive to the biological samples and the bio- 	 numerous experiments to sample a multidimensional, multi- 
logical system represented by a biological sample returned to 	 variable stimulus space, and then processing response data to 
its original state after each stimulation iteration. In various 	 seek combinations of stimuli resulting in more desired 
embodiments, sensor measurements are used that are invasive 	 responses, the systems and methods of the invention process 
procedures, such as, for example without exclusion: cell lys-  5o response data to direct the combinations of stimuli used for 
ing; transfection; permeabilization of cell membranes; intra- 	 subsequent manufacturing processing steps (e.g., iterative 
cytoplasmic injections; illumination with electromagnetic 	 steps), or experiments, to generate subsequent data or manu- 
waves; application of radioactive elements; application of 
	
facturing protocols. This can reduce the number of develop- 
fluorescent labeling; fixation; and flow cytometry. These 	 mental manufacturing processing steps, or experiments, 
invasive procedures can occur in between discrete measure-  55 required for optimization by avoiding conducting experi- 
ments, or during continuous measurement and/or real time 	 ments in unpromising directions. In some embodiments, a 
monitoring procedures. Such invasive procedures may induce 	 stochastic search algorithm, iteratively determines the inputs 
unwanted effects on the system and should be eliminated or 	 (stimuli) for achieving a desired response of the system (bio- 
minimized. In some aspects, as appropriate, a sample sub- 	 logical sample). Such embodiments go beyond using feed- 
jected to such invasive procedures should not be reused dur-  6o back and control for maintaining sustaining conditions for a 
ing a subsequent test iteration. In some embodiments multiple 	 biological sample, as is known in the art, by using feedback 
samples of the same type can be started in parallel testing. At 	 and control to control the selection of stimuli for experiments. 
each test iteration, one of the samples is invasively measured 
	
Any known stochastic search algorithm can be used in 
and then discarded, with the iterative testing being continued 	 practicing the systems or methods of the invention; and 
with the other samples. In this way, measurements can then be 65 examples of well known stochastic search algorithms 
done on samples that have not been invasively treated at each 
	
include, without exclusion: simulated annealing; stochastic 
iteration, but otherwise share a common history. 	 local search; stochastic hill-climbing; Metropolis-Hastings 
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sampler; greedy randomized adaptive search; evolutionary 	 Such randomness in a search algorithm can provide a gener- 
algorithm; genetic algorithm; taboo search; and/or Gur 	 alized way to handle such unknown and unpredictable issues. 
Game, or variations or combinations thereof. 	 Embodiments of the invention comprising stochastic search 
As discussed below, we have demonstrated Gur Game as 	 algorithms can be especially useful for studying living bio- 
an effective stochastic search algorithm in practicing the 5 logical systems, unlike other biochemical systems whereran-
methods of the invention; see Examples below, for a study of 
	
domness is not as important. 
cytokine combination optimization. Much like a genetic algo- 	 Various embodiments can employ various methods to 
rithm, the Gur Game aims for self-organization and self- 	 implement this random decision making. The randomness 
optimization of the system. The essence of the Gur Game, 	 itself can be within a certain range, adjusting according to a 
including the forms used in practicing the invention, is a io pre-defined way, or adjusting according the dynamic 
biased random walk toward the global optimum. 	 response of the system's parameters. 
The essential concept in the Gur Game, including the forms 	 Other control schemes can be incorporated into other 
used in practicing the invention, is the global figure of merit, 	 embodiments for studying biological samples. Such control 
called the reward function, which measures the performance 	 schemes can be classified by the level of prior knowledge 
of the system as a whole. To implement the algorithm, each 15 required in order to implement the algorithm. 
input (e.g. a cytokine) is represented by an automaton with a 	 In one model-based control used to practice this invention, 
pre-defined set of discrete states. In general, there is no spe- 	 a physical system (a plant, in control terminology) is used, as 
cific limitation on the choice of the states in the automaton 	 described by a mathematical model. Then a controller, e.g. 
and different inputs can have different number of states and 
	
LQR (linear quadratic regulator) or PID (proportional-inte- 
state values. During the study, each automaton move from one 20 gral-derivate), can be designed according to the output 
state to another based on being rewarded for their behavior. 	 requirements. In one aspect, among all the available control 
This "reward" probabilistically drives the system to the 	 schemes, a model based controller can provide the best per- 
desired output states. More specifically, the output value (re- 	 formance assuming the system is described reasonably accu- 
ward value) is compared to a random number. If the reward 	 rate by the model and all essential components are consid- 
value is larger than the random number, the automaton is 25 ered. However, it can be difficult to regulate unknown signal 
rewarded. Otherwise, the automaton is penalized. In other 	 transduction networks by using model-based controller with- 
word, the reward values determine the chances that an 	 out an adequate model. 
automaton is "rewarded" at different iterations. This process 	 Another type of controller used to practice this invention 
is repeated for each actuator during each iteration. Eventually 	 involves identification of the model and the model param- 
a global optimal state is achieved. 	 so eters. For example, neural network (NN) and design of 
Modifications or variations of a Gur Game, multiple out- 	 experiment (DOE) type controllers belong to this category. In 
put, multiple reward values, and multiple set of measure- 	 general, the more unknown parameters, the more data is 
ments can be used to practice the invention. In one aspect, the 	 required by the controller. In one aspect, as in a typical bio- 
predefined set of discrete state values can be changed dynami- 	 logical network, the system of the invention uses a large 
cally according to the current or recent inputs and outputs 35 number of dynamic parameters. The fitting parameters are 
relationship. In one aspect, the time period of each iteration 	 mainly determined by minimizing the deviations between 
can be changed dynamically. As noted above, other algo- 	 measurements and model predictions. If the basic structure of 
rithms used to practice the invention include smart non-linear 	 network is known or large amount of data is available, the 
optimization search algorithms such as simulated annealing, 	 identification approach can be extremely useful. For example, 
stochastic local search, stochastic hill-climbing, metropolis- 40 in one aspect, techniques such as neural network are used to 
Hastings sampler, and variations thereof. 	 predict and control highly nonlinear systems. However, the 
An advantage of stochastic search algorithms are that only 	 identification methods could be misleading for certain net- 
minimal prior knowledge of the system to be optimized is 	 works and over-fitting can occur when high quality experi- 
required and the controller can calculate subsequent iteration 	 mental data is not available. 
inputs rapidly. The exemplary simulated annealing, stochas-  45 	 Another category of controller used to practice this inven- 
tic local search, stochastic hill-climbing, Metropolis-Hast- 	 tion is rule based techniques, such as local search and sto- 
ings sampler, greedy randomized adaptive search, evolution- 	 chastic search algorithms, such as described in more detail, 
ary algorithm, genetic algorithm, taboo search, Gur Game 	 below. 
algorithms are all exemplary sampling stochastic search algo- 	 In practicing the invention, when using stochastic search 
rithms that can be used to practice this invention, and all are 5o algorithms, the system for optimization or manipulation can 
well known in the art. Stochastic search algorithms have been 	 be a response (or set of responses) corresponding to a respec- 
shown to be effective in a variety of applications in science 	 tive set of stimuli for discrete iterations. In one aspect, the 
and engineering as reported in the open literature. In one 	 stimulation to response time interval for a system for optimi- 
aspect, a stochastic search algorithm can include at least one 	 zation or manipulation can be small compared to the interval 
system performance goal, such as a reward function, which an 55 between iterations, this pairing of data can uniquely charac- 
algorithm attempts to optimize (e.g. minimize, maximize or 	 terize a system at each iteration. On the other hand, if the time 
to reach a constant value). This defines a goal for overall 	 interval is long compared to an iteration, the system's 
system performance. Other aspects use algorithms for driving 	 memory of prior stimuli can affect its response to present 
a system towards better output, such as, for example, local 	 stimuli. In such cases dynamical or "analog" implementa- 
gradient, probability of an event, or "evaporation" of certain 60 tions can be used; i.e. the system itself determines the proper 
parameters. A stochastic search algorithm used to practice 	 input waveform/duration and output measurement time. The 
this invention can also include randomness in directing 	 resulting dimensionality of search space can, however, sig- 
search. Such randomness, can enable the algorithm escape 	 nificantly increase in such cases. 
from a local optimum when there could be a better local or 	 The terms optimum, optimized, and optimization as used 
global optimum. Avoiding entrapment in local optima can be 65 herein can refer to an improved, or more desirable biosystem 
especially important in searching complex biological systems 	 response, even though the response may actually not be at an 
that tend to be noisy, stochastic, active, and/or dynamical. 	 absolute optimum. 
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Computer Systems and Computer Program Products 
The invention provides articles (e.g., computer program 
products) comprising a machine-readable medium including 
machine-executable instructions, computer systems and 
computer implemented methods to practice the methods of 
the invention. Accordingly, the invention provides comput-
ers, computer systems, computer readable mediums, com-
puter programs products and the like having recorded or 
stored thereon machine-executable instructions to practice 
the methods of the invention. As used herein, the words 
"recorded" and "stored" refer to a process for storing infor-
mation on a computer medium. A skilled artisan can readily 
adopt any known methods for recording information on a 
computer to practice the methods of the invention. The meth-
ods of the invention can be practiced using any program 
language or computer/processor and in conjunction with any 
known software or methodology. Some embodiments can use 
analog, or hybrid analog/digital circuitry for feedback and 
control, such as for example, neural networks, in which the 
control algorithm could be "hard wired." The term computer 
product as used herein can refer to any of such above embodi-
ments. 
Another aspect of the invention is a computer readable 
medium having recorded thereon machine-executable 
instructions to practice the methods of the invention. Com-
puter readable media include magnetically readable media, 
optically readable media, electronically readable media and 
magnetic/optical media. For example, the computer readable 
media may be a hard disk, a floppy disk, a magnetic tape, 
CD-ROM, Digital Versatile Disk (DVD), Random Access 
Memory (RAM), or Read Only Memory (ROM) as well as 
other types of other media known to those skilled in the art. 
The computer/processor used to practice the methods of 
the invention can be a conventional general-purpose digital 
computer, e.g., a personal "workstation" computer, including 
conventional elements such as microprocessor and data trans-
fer bus. The computer/processor can further include any form 
of memory elements, such as dynamic random access 
memory, flash memory or the like, or mass storage such as 
magnetic disc optional storage. For example, a conventional 
personal computer such as those based on an Intel micropro-
cessor and running a Windows operating system can be used. 
Any hardware or software configuration can be used to prac-
tice the methods of the invention. For example, computers 
based on other well-known microprocessors and running 
operating system software such as UNIX, Linux, MacOS and 
others are contemplated. As used herein, the terms "com-
puter," "computer program" and "processor" are used in their 
broadest general contexts and incorporate all such devices. 
The invention will be further described with reference to 
the following examples; however, it is to be understood that 
the invention is not limited to such examples. 
EXAMPLES 
The following examples are provided to illustrate, but not 
limit, embodiments of the invention. In the first example, 
nearly optimal combinations of cytokines are determined for 
regulating transcription activity. This example represents a 
use of an embodiment of the present invention for additional 
applications of the invention, e.g., vaccine production opti-
mization, drug screening, determining therapeutic regimens 
for the treatment of diseases, toxicity studies, and the like. In 
the second example, another embodiment of the invention is 
used to direct activation and differentiation of neural stem 
cells for tissue engineering applications. In the third example, 
a method for manipulating and discovering artificial gene and 
22 
metabolic networks is described. The third example illus-
trates the use of an embodiment the present invention to 
mimic and study biological processes. 
5 	 Example 1 
Optimizing a Combination of Cytokines to Regulate 
Transcription Factor NF-KB 
io As a first example, we applied the Gur Game algorithm 
(one of the exemplary optimization algorithms used to prac-
tice the invention) for regulating the activity of a polypeptide, 
a transcription factor called nuclear factor kappa B (NF-KB). 
This example demonstrates that the systems and methods of 
15 the invention can effectively measure and manipulate envi-
ronmental parameters in a bioreactor, and manipulate and 
optimize a biological system (in this example, regulating the 
expression and/or activity of a polypeptide). 
NF-KB regulates expression of numerous genes that medi- 
2o ate survival, apoptosis, proliferation, inflammatory response, 
and oncogenesis, and is reported to be one of the major drug 
targets for cancer and chronic inflammatory diseases. The 
NF-KB activity can be controlled by several signal transduc-
tion pathways and numerous stimuli can trigger the activities 
25 of one or more kinases that activate NF-KB. Determining a set 
of cytokines and growth factors that exerts desired effects on 
NF-KB can be a crucial step for realizing the therapeutic 
potential of targeting NF-KB. At the same time, the nonlinear 
interactions among the pathways and the large parametric 
so space constituted by the combinatory cytokines impose a 
major challenge. 
An advantage of an embodiment using the Gur Game as a 
search algorithm for implementation on the controller is that 
the Gur Game does not require an a priori model of the 
35 system. Gur Game can be robust and used to make random 
changes in the system and the environment. Therefore, exem-
plary systems and methods of the invention comprising use of 
Gur Game as an optimization algorithm is good choice for 
controlling complex biological systems for which adequate 
40 modeling of the governing networks is lacking. The Gur 
Game can be viewed as being based on biased random walks 
of multiple finite state automata toward higher system perfor-
mance, as defined by a reward function. The asymptotic 
behavior of the automata has been modeled using the Markov 
45 chain analysis. The reward function of the system can be 
multi-modal, nonlinear, and even discontinuous. 
To implement the Gur Game algorithm, each cytokine was 
represented by an automaton with 10 discrete states (0, 0.25, 
0.5, 1, 2.5, 5, 10, 25, 50, and 100 ng/ml) as shown in FIG. 6. 
5o At each iteration, a combination of cytokines at their respec-
tive states was applied to stimulate the cells for one hour. The 
transient response of GFP intensity was observed to approach 
a maximum at about seven hours after stimulation, coinciding 
with reports in the open literature. The choice of cytokines or 
55 combination of cytokines did not show an observable effect 
on the transient response of the fluorescence intensity. The 
GFP expression kinetics is thought to be controlled by protein 
folding and degradation rates, while the amount of transcrip-
tion (GFP intensity) is thought to provide an indication of the 
6o NF-KB activity. The peak intensities were normalized as the 
reward function for Gur Game. The reward function maps the 
system state from 0 to 1, with high GFP intensity corresponds 
to values nearer 1. For each automaton, a random number 
from 0 to 1 is chosen and compared with the reward value. 
65 The next states of the automata were determined according to 
a prescribed manner (see FIG. 1). The process was repeated 
for each cytokine during each iteration. 
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Referring again to FIG. 6, each cytokine as represented by 
an automaton. The numbers represent the concentration of the 
cytokines, in ng/ml. During each iteration, a random number 
was generated for each automaton. The numbers were com-
pared to the reward value. If the reward value was larger than 
the random number, the automaton was rewarded (win). Oth-
erwise, the automaton was penalized (lose). The automaton 
then decided the state in the next iteration according to the 
automaton design. Generally, the state moves toward center if 
penalized, and away the center if rewarded. 
Microfluidic systems have been proven to be effective for 
manipulating different biological objects, such as cells and 
molecules. In this example, the optimization experiments 
were conducted inside microfluidic channels to facilitate real-
time monitoring and dynamic stimulation of the cells. At each 
iteration, the cells were transiently stimulated with a combi-
nation of agonists for one hour as shown in FIG. 7A. (In FIG. 
7a, the concentrations of individual cytokines are indicated as 
follows: TNFa: concentrations are plotted as solid squares; 
TNFP concentrations are plotted as solid circles; IL-la con-
centrations are plotted as solid triangles; IL-I P concentra-
tions are plotted as inverted triangles; EEG concentrations are 
plotted as open squares; and BAFF concentrations are plotted 
as open circles.) The initial concentrations of the cytokines 
were 2.5 ng/ml. In order to monitor the activity of the NF-KB, 
a plasmid with a green fluorescent protein (GFP) reporter 
gene was placed in the 293T cell. The GFP expression is 
controlled by a promoter which consisted of a kappa enhancer 
element (KB,). Similar configurations have been applied in 
other studies where the GFP fluorescence intensity was able 
to reflect the cellular NF-KB activity. In addition, computa-
tional analysis was performed to correlate the relationship 
between the expression level of GPF and the activity of NF-
KB. Numerical simulation indicated the best duration and 
time for cytokine stimulation and GFP intensity measure-
ment. The GFP fluorescence intensity of each cell was 
recorded 7 hours after the stimulation as shown in FIG. 7B 
(data represent the average intensity of 40-128 cells). 
The Gur Game was used to determine the cytokine con-
centrations in subsequent iterations to probabilistically drive 
the system toward a high GFP output, i.e. high NF-KB activ-
ity. FIG. 6 is a flow chart illustrating an exemplary Gur Game 
Algorithm, the algorithm used in this example. A detailed 
description of this exemplary algorithm is set forth above. 
The peak intensities were normalized as the reward function 
for this exemplary Gur Game algorithm. The reward function 
maps the system state from 0 to 1, with high GFP intensity 
corresponds to values nearer 1. For each automaton, a random 
number from 0 to 1 is chosen and compared with the reward 
value. 
The next states of the automata were determined according 
to a prescribed manner, as illustrated in FIG. 7. The process 
was repeated for each cytokine during each iteration. Each 
cytokine as represented by an automaton. The numbers rep-
resent the concentration of the cytokines, in ng/ml. During 
each iteration, a random number was generated for each 
automaton. The numbers were compared to the reward value. 
If the reward value was larger than the random number, the 
automaton was rewarded (win). Otherwise, the automaton 
was penalized (lose). The automaton then decided the state in 
the next iteration according to the automaton design. Gener-
ally, the state moves toward center if penalized, and away the 
center if rewarded. 
Referring to FIGS. 8a and 8b, initially, the system rejected 
several cytokine combinations with seemingly high outputs. 
At iteration 17, the system determined a potent combination 
of cytokines for activating the NF-KB signal transduction 
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pathways. Due to the random walk nature of the Gur Game, 
the system did not settle even with the large performance 
gains at iteration 17. The algorithm continually searched for 
other states with better performance. It is seen that the reward 
5 function decreased significantly for several iterations during 
the search. However, the system robustly returned to the 
similar NF-KB activity at iterations 23 & 28. This most potent 
cytokine combination, which was determined by the final 
10 
probability distributions of the cytokine concentration (see 
supplementary material), was TNFa=25 ng/ml, TNFP -50 
ng/ml, IL-1a=50 ng/ml, IL -1R=25 ng/ml, EGF=2.5 ng/ml, 
BAFF=2.5 ng/ml. The robustness of the Gur Game algorithm 
is further illustrated by the observation that the paths by 
15 which the cytokine combinations moved toward the peak 
were different. In principle, an even larger parametric (input 
variable) space, e.g. 7, 8 or more cytokines with 10 7, 10$ or 
more combinations, is expected to achieve a similar rapidly 
converging rate by using the stochastic searching in a feed- 
20 back loop. FIG. 8C shows normalized GFP intensity at dif-
ferent iterations for the cytokine combination and individual 
cytokine (TNFa). In FIG. 8C, the dynamic responses of NF-
KB activity for cells treated withthe cytokine combination are 
plotted as solid circles, the dynamic responses of NF-KB 
25 activity for cells treated with TNFa 50 ng/ml are plotted as 
asterisks, andthe control dynamic responses of NF-KB activi-
ties are plotted as open circles. Data represent the mean±SEM 
(standard error of the mean, numerically: 
30 
S 
sx 
 = n , 
35 	 where S is the standard deviation and n is the number of 
measurements) from at least 100 cells inside the microfluidic 
channels. 
With the most potent combination of cytokines efficiently 
determined by the closed-loop feedback control scheme of 
40 the embodiment, the concentration of a specific cytokine was 
then varied, while the concentrations of the others were held 
constant to understand the sensitivity of the specific cytokine 
as shown in FIGS. 8A through 8F. For FIGS. 8A through 8F, 
the data show mean±SEM of at least 300 cells. Experiments 
45 were conducted in 96-well plates. The cells were stimulated 
with the appropriate concentration of cytokines for one hour 
and washed with fresh media. Fluorescence measurements 
were carried out 7 hours after stimulations.) TNFa was found 
to be the most sensitive in the combination in affecting the 
5o activity of NF-KB. Elimination of TNFa in the cytokine com- 
bination resulted in a —50% decrease in fluorescence inten- 
sity. Total elimination of any one of TNFP, IL-la or IL- IP 
resulted in —30% decrease in fluorescence intensity. The sen- 
sitivity curves of TNFa and R  (FIGS. 8A and 813) exhibited 
55 "peaky" patterns while the curve patterns for IL-la and R 
(FIGS. 8C and 8D) were smoother. The effects of IL-1 a and 
IL- I P were not sensitive to their concentrations in the range of 
25-50 ng/ml. When combined with the potent cytokine com- 
bination, EGF decreased the NF-KB activity with increasing 
6o dose concentration (FIG. 8E). It should be noted that EGF 
alone did not show a strong effect on the NF-KB activity in 
293T cells (data not shown). For the case of BAFF, it had a 
minimal effect on NF-KB activity with or without the potent 
cytokine combination (FIG. 8F). It is interesting to note that 
65 the Gur Game search algorithm suggested lower and lower 
concentrations of both EGF and BAFF as the iterations pro- 
ceeded (FIG. 7A). These data clearly indicate that the effects 
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of individual cytokines are not additive in the combinatory 	 for optimum (or nearly optimum) stimulation to direct stem 
tests and the interactions among pathways are nonlinear. 	 cells to desired expressions. With these apparatus and method 
embodiments, NPCs' physiology that is concerned with the 
Example 2 	 cytokine stimulation, as well electrical activity associated 
5 with living cells and involved in their functional activity can 
Directed Neural Stem Cell Differentiation with 
	
be studied in a fast pace. Important mechanisms of NPCs 
Biochemical and Physical Stimuli by an Intelligent 	 response to cytokines and electrical activity, such as depolar- 
Closed-Loop Control Algorithm 	 ization ion, electrodeformation, and associated signal trans- 
duction pathway can be studied in detail. Migration, prolif- 
As a second example of the use and effectiveness of an io eration, neurogenesis, and remyelization of NPCs under 
exemplary embodiment of the invention, the activities and 	 external electric fields, cytokine exposures, and ECM can be 
differentiation of stem cells were investigated, specifically 	 characterized. The information obtained can enable the selec- 
the activities and differentiation of neural progenitor cells 	 tion of operating parameters of electrical and other biomedi- 
(NPCs), which are promising areas for tissue engineering 	 cal stimulation in clinical therapeutic approaches, such as 
applications. This exemplary example demonstrates that the 15 neural prosthesis, stem cell implantation, and stimulation of 
systems and methods of the invention can be used to deter- 	 endogenous progenitor cells for the replacement of lost neu- 
mine parameters for the direction of cell behavior, e.g., stem 	 ral functions. ECM is extracellular matrix. ECM is a complex 
cell behaviors. This example demonstrate that the composi- 	 network of polysaccharides and proteins secreted by cells and 
tions and methods of the invention can be used for systems 	 a structural component of tissues that also influences their 
manipulation and/or optimization of a biological manufactur-  20 development and physiology. 
ing, cell engineering, or experimental systems related to cell 
	
In one aspect, cells can be obtained from human fetal tissue 
behavior, including cell growth or differentiation, e.g., in 	 between 14 and 21 weeks post conception, and then cultured. 
bioengineering systems for reconstructing or regrowing tis- 	 NPCs can also be isolated and cultured from human brain 
sue or organ systems, e.g., in nervous system, muscle or liver 	 tissue for the first several years of life. The NPCs can be 
damage repair, or, in bioreactors for the production of pro-  25 cultured in (DMEM):HAMS F12 at about (50:50), gentami- 
teins, polypeptides or peptides for vaccines; including 	 cin at about 30 mg/ml, amphotericin B at about 15 µg/ml, 
manipulation and/or optimization of systems for differentiat- 	 human recombinant basic fibroblast growth factor (FGF-B) 
ing cells to a desired state or having a specific property, e.g., 	 and epidermal growth factor (EGF) both at about 20 ng/ml, 
ability to produce or modify a polypeptide, e.g., a therapeutic 	 and N2 at about 1:100. 
protein, polypeptides or peptides for vaccines, and the like. 30 	 Before each experiment, the cells are incubated in a 
A promising approach for treatments of nervous system 	 approximately 5% CO2 atmosphere incubator at approxi- 
damages is cell-replacement therapy. Several recent studies 	 mately 37° C. for about 24 hours, allowing them to recover 
have been described in the open literature on transplantation 	 from cryopreservation prior to use in the adhesion and pro- 
of neural precursor/stem cells into the rodent model of spinal 
	
liferation assays. The cells can then be cultured on a microf- 
cord injury. While cell transplantation therapy has shown 35 luidic bioreactor device, according to an embodiment of the 
promises as a clinical treatment, the approach processes sev- 	 invention. Actuators, such as micro- and nano-electrodes, 
eral concerns. For instance, transplantation of undifferenti- 	 extracellular matrices, growthfactors, and differentiationfac- 
ated cells could result in low engraftment efficiency and 	 tors, can be integrated into microfluidic bioreactor. These 
therefore reduced clinical efficacy. Undifferentiated progeni- 	 stimuli can be directly control with a computer serving as a 
tor cells may cause spontaneous differentiation into undes-  40 controller. The cell's behavior, including migration, prolif- 
ired lineages. Most importantly, it processes the risk of ter- 	 eration, and lineage specific markers (Tujl for neuron, RIP 
atoma formation, in the case of embryonic stem cells. Ex vivo 	 for oligodendrocyte and GFAP for astrocytes) can be moni- 
differentiation of NPCs provides a promising alternative, 	 tored in real time and continuously and served as biological 
which may minimize the previously mentioned concerns. For 	 responses from which reward functions (in Gur Game and 
differentiation of neural cells prior to transplantation, the 45 other stochastic search/nonlinear optimization terminology). 
commitment could be overridden by environmental cues in 	 The information obtained in the measurement can then be fed 
the injured spinal cord. Large scale directed differentiation, 	 into the Gur Game algorithm or other stochastic search algo- 
separation, and purification of target cells still presents chal- 	 rithms to determine next iteration stimuli in the search for 
lenges. It is generally believed that more basic and preclinical 
	
better combinations of stimuli for more nearly optimal 
research must be done before attempting human trials using 5o responses. Synergistic and antagonistic effects of stimuli can 
stem cell therapies to repair the damaged nervous system. 	 also be studied in this way. 
There are many fundamental questions still to be answered 
	
As described above, this embodiment of the invention can 
either for developing replacement cells or activating the 	 determine optimal (or nearly optimal) operating parameters 
body's own stem cells in vivo. An embodiment of the present 	 of electrical and other biochemical stimulation to direct the 
invention provides a unique tool to determine parameters for 55 neural progenitor cells to differentiate into cells with desired 
the direction of stem cell behaviors. 	 phenotypes. This can pave the way for novel treatments of 
One embodiment of the present invention can be used to 	 degenerative diseases of the nervous system. One set of goals 
systematically investigate the effects of cytokines, growth 
	
is to determine the proper conditions for the differentiation of 
factors, extracellular matrix environment, and electrical 
	
NPCs to specific neural cells, such as oligodendrocytes and 
activity on growth and differentiation. Similar to most bio-  60 motor neurons, for SCI and ALS treatments. While direct 
logical systems, a stem cell's activity and differentiation can 	 differentiation of NPCs is clearly useful, other aspects of the 
depend on a large number of exogenous parameters, in which 	 neural activity can also be considered. In many spinal inju- 
stimuli, their respective magnitudes, their respective tempo- 	 ries, the spinal cord is not fully damaged and some of the 
ral and spatial gradients, and their interactions can be impor- 	 signal-carrying neuronal axons are intact. However, the sur- 
tant to the determination of a differentiated phenotype and the 65 viving axons no longer carry messages because oligodendro- 
fate of the differentiated phenotype. Embodiments of the 	 cytes are lost. One possibility is to direct the migration or 
present invention can mimic in vivo environments and search 
	
directly implant neural progenitor cell to the injury site and 
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stimulate their differentiation in situ into appropriate support- 	 for about 5 min. Cell adhesion occurs preferentially in regions 
ing cells, such as oligodendrocytes. Another possibility is to 	 withpoly-L-lysine modification. The number of cells adhered 
differentiate neural progenitor cells in vitro and direct the 	 on the channel surface can be adjusted by adjusting the cell 
differentiated cells into the injury site. With various embodi- 	 concentration in the solution and residency time of the cells in 
ments of the present invention, many important aspects of the 5 the channel. Non adherent cells can then removed by washing 
neural processes can be investigated, including for example: 	 with culture medium. 
(i) the migration of NPCs and glia cells; (ii) the survival and 	 The microfluidic chip (bioreactor, see FIG. 2) can be 
proliferation of NPCs; (iii) the differentiation of NPCs to 	 loaded onto an epifluorescence microscope (for example a 
specific cell types of the nervous system; and (iv) remylena- 	 Nikon TE 200TM) equipped with an ultraviolet light source 
tion of differentiated oligodendrocytes. 	 io (e.g., a 100 W mercury lamp). A thermolectric hot and cold 
stage (e.g. Instec, HCS60 with a platinum RTD temperature 
Example 3 	 control sensor) can be mounted on the microscope. This can 
be used to maintain the temperature of the microfluidic chip at 
Iterative Methods for Discovering, Manipulating aid 	 about 37° C. with a PID feedback controller (for example, 
Optimizing Natural and Artificial Gene Networks 	 15 Instec, STC200TM) for the gene expression experiments. The 
two inlets of the microfluidic chip (21 and 22 of FIG. 2) can 
This example demonstrates that the systems and methods 	 be connected to reservoirs of desired fluids. A peristaltic 
of the invention can be applied to design, manipulate, under- 	 pump (e.g., Instech, P625) can be connected at the outlet (25 
stand and/or optimize (or nearly optimize) natural and artifi- 	 of FIG. 2) for fluid aspiration. The configuration allows for 
cial gene and metabolic networks, including neural networks 20 substantially identical flow rates from the two inlets, thereby 
and similar biological systems, such as metabolic, growth, 	 promoting the generation of a stable chemical gradient in 
apoptotic or differentiation networked systems. This example 	 zig-zag section 23 (FIG. 2) of the microfluidic chip 11. The 
also demonstrates that the systems and methods of the inven- 	 flow rate can be adjusted from about 1-400 ld/min and can be 
tion can be applied to mimic in vivo neural, gene and/or 	 calibrated with a pressure transducer (e.g., Honeywell, 
metabolic networks. 	 25 ACSXTM series). Fluorescence and bright-field images can be 
In nature, biological systems such as gene and metabolic 	 imaged by, for example, a 16 bit, 1024 by 1024 pixel cooled 
networks have been observed to express themselves in vari- 	 CCD camera (such as a Photometric CH350LTM) periodically 
ous ways, such as circadian clocks and auto-regulated gene 	 at a predefined period of roughly 1-5 min intervals and 
expressions, for example. It is of great interest to understand, 	 recorded on an appropriate medium. Light sources can be 
control, and mimic such gene and metabolic networks both in 30 shuttered between exposures. Approximately two to three 
living organisms (in vivo) and artificially (in vitro). However, 	 hundreds cells can be captured in the field of view in one 
such networks tend to be sensitive to a large number of inter- 	 image. This embodiment can be combined with image analy- 
cellular factors (e.g. secreted factors, quorum, etc.), intracel- 	 sis software for automated processing. 
lular factors (e.g. genes, promoters, pathway components, 	 Spatial chemical gradients can be generated by merging 
etc.), and extra cellular parameters (e.g. carbon sources, pH, 35 streams of media and reagents of various concentrations. The 
temperature, light intensity, and other biochemical reagents 	 concentration gradients of chemical can be experimentally 
etc). Without a detailed understanding of such stimuli and 	 determined by fluorescence intensity. Different concentra- 
their interactions, it is difficulty to understand, control, and/or 	 tions of IPTG in M9 medium can be tested. The inducer 
mimic the robustness, functionality, and properties of these 	 concentration distribution in the gene expression experiment 
metabolic networks. Embodiments of the present invention 40 can be estimated by numerical simulation (CFDRC) with 
can obviate the need for a full understanding of metabolic 	 diffusivity 8.80x10 -6 cm2/sec for IPTG at 37° C. 
networks, while indicating appropriate environment cues 	 Stimuli, such as inducers, carbon sources, temperature, 
(stimuli) for desired metabolic network responses. 	 pH, cell densities; and internal gene circuit parameters, such 
Oscillatory networks in E. coli have been described in the 	 as promoter activities, transcription rates, translation rates, 
open literature, however the role and influence of environ-  45 maturation rates, and metabolic reaction rates, can be studied 
mental cues (stimuli) remain unclear. An embodiment of the 	 and tested with this embodiment. The biological sample out- 
present invention can be used to determine external signals 	 puts, such as GFP intensity, frequency, number of mitosis 
required to activate and/or modulate an oscillatory network 	 cycles, and cell-cell variations, can be monitored and 
(in this or any other system). E. coli can be cultured in microf- 	 recorded with a CCD camera in some embodiments. The Gur 
luidic systems fabricated by micromolding of polydimethyl-  50 Game algorithm or other stochastic search algorithm can be 
siloxane (PDMS) on photoresist master. In an embodiment of 	 applied to optimize (or nearly optimize) stimuli to elicit a 
a microfluidic bioreactor, as described above. Poly-L-lysine 	 desired response from the biological sample in various 
(Sigma, P 8920) can be applied at desired locations in the 	 embodiments (for example, maximizing the frequency of 
microfluidic device using a pipette or a sharpened glass cap- 	 GFP oscillation frequency) Since biochemical reactions can 
illary to achieve selective cell depositions. Patterns on the 55 generally be speeded up by increasing temperature, it is likely 
order of 10 µm can be printed with this method. For instance, 	 that temperature is an important factor for the maximizing the 
patterns of roughly 500 µm (field of view of the optical 	 frequency. Typically, bacteria are cultured at 30° C. to 37° C., 
system) can be printed in order to trap multiple cells for 	 which is a reasonable range for initial testing. However, 
statistical analysis. The channel can then sealed by a piece of 
	
increase in temperature may alter the dynamics of the reac- 
cover slip. Before sealing, holes can be drilled on the glass for 60 tions and overheat enzymes, thereby reducing their activities. 
interconnections. The microfluidic channel can be washed by 	 The doubling rate, which affects the protein dynamics in a 
flowing phosphate buffered saline (PBS) for about 5 min. The 	 variety of ways, can also be changed. Other parameters, such 
solution can then be switched to about 10 mg/ml of bovine 	 as pH, can also affect a metabolite's transportation rates and 
serum albumin in PBS for about 5 min. This process can 	 other reaction kinetics and, therefore, the overall perfor- 
reduce the non-specific binding of cells the in the channel. 65 mane (frequency) of the gene network. In general, the criti- 
The channel can then be filled with a suspension of the E. coli 	 cal parameters are unknown and the interactions of these 
cells and the cells are allowed to adhere to the channel surface 	 parameters are unclear. 
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Embodiments of the present invention with a stochastic 
search algorithm can provide a systematic method for deter-
mining the optimal combination for maximizing the fre-
quency and provide important insights for understanding the 
important parameters (stimuli) and their interactions. 
It will be appreciated that the above description for clarity 
has described exemplary embodiments of the invention with 
reference to different functional units and processors. How-
ever, it will be apparent that any suitable distribution of func-
tionality between different functional units or processors may 
be used without detracting from the invention. For example, 
functionality illustrated to be performed by separate proces-
sors or controllers may be performedby the same processor or 
controllers. Hence, references to specific functional units are 
only to be seen as references to suitable means for providing 
the described functionality rather than indicative of a strict 
logical or physical structure or organization. 
The invention can be implemented in any suitable form 
including hardware, software, firmware or any combination 
of these. The invention may optionally be implemented at 
least partly as computer software running on one or more data 
processors and/or digital signal processors. The elements and 
components of an embodiment of the invention may be physi-
cally, functionally and logically implemented in any suitable 
way. Indeed the functionality may be implemented in a single 
unit, in a plurality of units or as part of other functional units. 
As such, the invention may be implemented in a single unit or 
may be physically and functionally distributed between dif-
ferent units and processors. 
Although the present invention has been described in con-
nection with some embodiments, it is not intended to be 
limited to the specific form set forth herein. Rather, the scope 
of the present invention is limited only by the accompanying 
claims. Additionally, although a feature may appear to be 
described in connection with particular embodiments, one 
skilled in the art would recognize that various features of the 
described embodiments may be combined in accordance with 
the invention. In the claims, the term comprising does not 
exclude the presence of other elements or steps. 
Furthermore, although individually listed, a plurality of 
means, elements or method steps may be implemented by e.g. 
a single unit or processor. Additionally, although individual 
features may be included in different claims, these may pos-
sibly be advantageously combined, and the inclusion in dif-
ferent claims does not imply that a combination of features is 
not feasible and/or advantageous. Also the inclusion of a 
feature in one category of claims does not imply a limitation 
to this category but rather indicates that the feature is equally 
applicable to other claim categories as appropriate. Further-
more, the order of features in the claims does not imply any 
specific order in which the features must be worked and in 
particular the order of individual steps in a method claim does 
not imply that the steps must be performed in this order. 
Rather, the steps may be performed in any suitable order. 
The figures provided are merely representational and may 
not be drawn to scale. Certain proportions thereof may be 
exaggerated, while others may be minimized. The figures are 
intended to illustrate various implementations of the inven-
tion that can be understood and appropriately carried out by 
those of ordinary skill in the art. 
Therefore, it should be understood that the invention can be 
practiced with modification and alteration within the spirit 
and scope of the appended claims. The description is not 
intended to be exhaustive or to limit the invention to the 
precise form disclosed. It should be understood that the inven- 
30 
tion can be practiced with modification and alteration and that 
the invention be limited only by the claims and the equivalents 
thereof. 
5 	 What is claimed is: 
1. A method for automatic optimization of a biological 
sample representing a biological system, comprising: 
(a) providing a system comprising the biological sample, 
wherein the system comprises at least one stimulator, at 
10 least one sensor operable to measure at least one param-
eter, and a controller operably connected to the at least 
one sensor and the at least one stimulator; 
(b) measuring at least one parameter in the biological 
sample, wherein the controller receives a signal from the 
15 	 at least one sensor; and 
(c) providing a stimulus from the at least one stimulator to 
the biological sample to alter the at least one parameter 
measured in step (b), or at least one other parameter, or 
a combination thereof, within the controller by running 
20 a Gur Game algorithm that does not require an a priori 
model of the system, wherein the algorithm determines 
the stimulus given to the biological sample, and the 
determination is based at least in part on the at least one 
parameter measured by the sensor in step (b), thereby 
25 automatically optimizing the biological sample to pro-
duce a desired biological response to the stimulus, 
wherein the algorithm is set to direct an iterative repeti-
tion of measuring at least one parameter in the system, 
actuating the at least one stimulator and measuring at 
30 least one parameter modified in response to the stimu-
lation, thereby manipulating and/or optimizing the bio-
logical system to achieve the desired biological 
response. 
2. A method for automatic manipulation of a biological 
35 sample representing a biological system, to achieve a desired 
biological response comprising: 
(a) providing a system comprising the biological sample, 
wherein the system comprises at least one stimulator, at 
least one sensor operable to measure at least one param- 
40 eter, and a controller operably connected to the at least 
one sensor and the at least one stimulator; 
(b) providing a first stimulus from the at least one stimu-
lator to the biological sample; 
(c) measuring at least one parameter in the biological 
45 sample in response to the first stimulus, wherein the 
parameter is measured by the controller receiving a sig-
nal from the at least one sensor; and 
(d) providing at least a second stimulus from the at least 
one stimulator to the biological sample to alter the at 
50 least one parameter measured in step (b), or at least one 
other parameter, or a combination thereof, to achieve the 
desired biological response, wherein the nature and 
amount of the at least second stimulus is determined and 
providedby running a Gur Game algorithm that does not 
55 require an a priori model of the system on the controller, 
and the determination is based at least in part on the at 
least one parameter measured by the sensor in step (c) to 
produce a desired biological response to the stimulus, 
wherein the algorithm is set to direct an iterative repeti- 
60 tion of measuring at least one parameter in the system, 
actuating at least one stimulator and measuring at least 
one parameter modified in response to the stimulation, 
thereby manipulating and/or optimizing the biological 
system to achieve the desired biological response. 
65 	 3. The method of claim 1 or claim 2, wherein the steps are 
iteratively repeated until the desired biological response is 
achieved. 
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4. The method of claim 1 or claim 2, wherein the desired 	 response, and the reward probabilistically drives the system 
biological response is sustaining or growing the biological 	 to the desired biological response. 
sample within a bioreactor. 	 18. The method of claim 1 or claim 2, wherein the algo- 
5. The method of claim 1 or claim 2, wherein the biological 	 rithm is set to direct a dynamic change in the time period of 
sample comprises a cell, a cell culture, a tissue, an isolated 5 each iteration. 
organ or an organ system or a cell isolate. 	 19. The method of claim 1 or claim 2, wherein the algo- 
6. The method of claim 1 or claim 2, wherein the biological 	 rithm is set to self-organize and self-optimize the automatic 
sample is a bacterial cell, a protozoan cell, an insect cell, a 	 manipulation of the biological sample. 
yeast cell, a plant cell or a mammalian cell, wherein option- 	 20. A computer-implemented method for automatically 
ally the mammalian cell is a human cell. 	 io optimizing production of a product by a biological system 
7. The method of claim 1 or claim 2, wherein the at least 	 comprising the method of claim 1 or claim 2. 
one parameter altered by the at least one stimulator comprises 	 21. A computer program product for automatically opti- 
an environmental condition in the system. 	 mizing production of a product by a biological system, 
8. The method of claim 7, wherein the environmental con- 	 wherein the computer program product comprises a non- 
dition altered by the at least one stimulator in the system 15 transitory machine-readable medium including machine-ex- 
comprises temperature, pH, oxygen or carbon dioxide con- 	 ecutable instructions, the instructions being operative to 
centration, nutrient or waste concentration, rate of exchange 	 cause a machine to run the computer-implemented method of 
of cell or tissue culture nutrients, rate of harvesting orremoval 	 claim 20. 
of a cell or tissue culture secreted product, cell growth or 	 22. A computer system comprising the computer program 
differentiation rate, cell concentration, or a combination 20 product as set forth in of claim 21. 
thereof. 	 23. A method for automatic optimization of a biological 
9. The method of claim 1 or claim 2, wherein the stimulus 	 sample representing a biological system, comprising: 
applied for altering the at least one parameter measured, or at 	 (a) providing a system comprising the biological sample, 
least one other parameter, or a combination thereof, within 	 wherein the system comprises at least one stimulator, at 
the system comprises a biochemical, electromagnetic, ther-  25 	 least one sensor operable to measure at least one param- 
mal, mechanical and/or optical stimulation. 	 eter, and a controller operably connected to the at least 
10. The method of claim 1 or claim 2, wherein the stimulus 	 one sensor and the at least one stimulator; 
applied for altering the at least one parameter measured, or at 	 (b) measuring at least one parameter in the biological 
least one other parameter, or a combination thereof, within 	 sample, wherein the controller receives a signal from the 
the system comprises a change in temperature, pH, oxygen or 30 	 at least one sensor; and 
carbon dioxide concentration, rate of exchange of cell or 	 (c) providing a stimulus from the at least one stimulator to 
tissue culture nutrients, rate of harvesting or removal of a cell 	 the biological sample to alter the at least one parameter 
or tissue culture secreted product, or a combination thereof. 	 measured in step (b), or at least one other parameter, or 
11. The method of claim 1 or claim 2, wherein the desired 	 a combination thereof, within the controller by running 
biological response from the biological sample is determin-  35 	 a stochastic search algorithm that does not require an a 
ing effectiveness of a drug combination cocktail on the bio- 	 priori model of the system, wherein the algorithm deter- 
logical sample. 	 mines the stimulus given to the biological sample, and 
12. The method of claim 11, wherein the desired biological 	 the determination is based at least in part on the at least 
response comprises growing, sustaining and/or differentiat- 	 one parameter measured by the sensor in step (b), 
ing the biological sample in the system. 	 40 	 thereby automatically optimizing the biological sample 
13. The method of claim 11, wherein the algorithm 	 to produce a desired biological response to the stimulus, 
manipulates a quantitative aspect and/or a qualitative aspect 	 wherein the algorithm is set to direct an iterative repeti- 
of the stimulus used to modify the one or more parameters in 	 tion of measuring at least one parameter in the system, 
the system to achieve the desired biological response from the 	 actuating at least one stimulator and measuring at least 
biological sample. 	 45 	 one parameter modified in response to the stimulation, 
14. The method of claim 11, wherein the desired biological 	 thereby manipulating and/or optimizing the biological 
response from the biological sample generated by the algo- 	 system to achieve the desired biological response, and 
rithm's manipulation or optimization of the system comprises 	 wherein the desired biological response from the bio- 
manipulation or optimization of: cell growth, cell differentia- 	 logical sample is determining effectiveness of a drug 
tion, cell vitality, synthesis or secretion of a naturally occur-  50 	 combination cocktail on the biological sample. 
ring or recombinant protein, a small molecule, an antibiotic, 	 24. A method for automatic manipulation of a biological 
a polysaccharide, a virus, a nucleic acid and/or a lipid. 	 sample representing a biological system, to achieve a desired 
15. The method of claim 14, wherein the naturally occur- 	 biological response comprising: 
ring or recombinant protein whose synthesis or secretion is 	 (a) providing a system comprising the biological sample, 
manipulated or optimized comprises a cytokine, an antibody 55 	 wherein the system comprises at least one stimulator, at 
or a structural protein. 	 least one sensor operable to measure at least one param- 
16. The method of claim 11, wherein the algorithm sets a 	 eter, and a controller operably connected to the at least 
global figure of merit to measure the performance of the 	 one sensor and the at least one stimulator; 
system as a whole to reach the desired biological response. 	 (b) providing a first stimulus from the at least one stimu- 
17. The method of claim 11, wherein the algorithm can 60 	 lator to the biological sample; 
assign each measured parameter any one of a pre-defined set 	 (c) measuring at least one parameter in the biological 
of discrete states, and different inputs for each parameter, or 	 sample in response to the first stimulus, wherein the 
different inputs for the same parameter over time, result in a 	 parameter is measured by the controller receiving a sig- 
different number of states and state values being assigned to 	 nal from the at least one sensor; and 
each parameter, and during manipulation and/or optimization 65 	 (d) providing at least a second stimulus from the at least 
of the biological system each automaton moves from one 	 one stimulator to the biological sample to alter the at 
state to another based on being rewarded for causing a desired 
	
least one parameter measured in step (b), or at least one 
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other parameter, or a combination thereof, to achieve the 
desired biological response, wherein the nature and 
amount of the at least second stimulus is determined and 
provided by running a stochastic search algorithm that 
does not require an a priori model of the system on the 
controller, and the determination is based at least in part 
on the at least one parameter measured by the sensor in 
step (c) to produce a desired biological response to the 
stimulus, wherein the algorithm is set to direct an itera-
tive repetition of measuring at least one parameter in the 
34 
system, actuating at least one stimulator and measuring 
at least one parameter modified in response to the stimu-
lation, thereby manipulating and/or optimizing the bio-
logical system to achieve the desired biological 
response, and wherein the desired biological response 
from the biological sample is determining effectiveness 
of a drug combination cocktail on the biological sample. 
